Misuse of Drugs Act
Part I Class A Drugs
Source: L. A. King, Forensic Chemistry of Substance Misuse: A Guide to Drug Control, RSC Publishing, Cambridge, 2009
1(a)
The following substances and products, namely:
3D rendering of Acetorphine
Acetorphine
CA: CDSA Schedule I Section 1 Subsection 5 Acetorphine
UN: Narcotics Part 1 Section 1 Acetorphine and Section 3 Acetorphine
US: CSA Schedule I Section c Subsection 1 Acetorphine
⇒
PubChem: 62795 20055090; ChemSpider: 16736130; Wikipedia: Acetorphine
3D rendering of Alfentanil
Effective 1 Jan 1985, S.I. 1984/859 added:
Alfentanil
CA: CDSA Schedule I Section 16 Subsection 2 Alfentanil
UN: Narcotics Part 1 Section 1 Alfentanil
US: CSA Schedule II Section c Subsection 1 Alfentanil
⇒
PubChem: 51263; ChemSpider: 46451; Wikipedia: Alfentanil
3D rendering of Allylprodine
Allylprodine
CA: CDSA Schedule I Section 3 Subsection 1 Allylprodine
UN: Narcotics Part 1 Section 1 Allylprodine
US: CSA Schedule I Section b Subsection 3 Allylprodine
⇒
PubChem: 32938; ChemSpider: 30495; Wikipedia: Allylprodine
3D rendering of Alphacetylmethadol
Alphacetylmethadol
CA: CDSA Schedule I Section 6 Subsection 2 Alphacetylmethadol
UN: Narcotics Part 1 Section 1 Alphacetylmethadol
US: CSA Schedule I Section b Subsection 4 Alphacetylmethadol
⇒
ChemSpider: 20937; Wikipedia: Alphacetylmethadol
3D rendering of Alphameprodine
Alphameprodine
CA: CDSA Schedule I Section 3 Subsection 2 Alphameprodine
UN: Narcotics Part 1 Section 1 Alphameprodine
US: CSA Schedule I Section b Subsection 5 Alphameprodine
⇒
PubChem: 61119; ChemSpider: 55067; Wikipedia: Meprodine
3D rendering of Alphamethadol
Alphamethadol
CA: CDSA Schedule I Section 6 Subsection 3 Alphamethadol
UN: Narcotics Part 1 Section 1 Alphamethadol
US: CSA Schedule I Section b Subsection 6 Alphamethadol
⇒
PubChem: 62709; ChemSpider: 56456; Wikipedia: Alphamethadol
3D rendering of Alphaprodine
Alphaprodine
CA: CDSA Schedule I Section 3 Subsection 3 Alphaprodine
UN: Narcotics Part 1 Section 1 Alphaprodine
US: CSA Schedule II Section c Subsection 2 Alphaprodine
⇒
PubChem: 11865413 6471; ChemSpider: 107780; Wikipedia: Prodine
3D rendering of Anileridine
Anileridine
CA: CDSA Schedule I Section 3 Subsection 4 Anileridine
UN: Narcotics Part 1 Section 1 Anileridine
US: CSA Schedule II Section c Subsection 3 Anileridine
⇒
PubChem: 8944; ChemSpider: 8600; Wikipedia: Anileridine
3D rendering of Benzethidine
Benzethidine
CA: CDSA Schedule I Section 3 Subsection 7 Benzethidine
UN: Narcotics Part 1 Section 1 Benzethidine
US: CSA Schedule I Section b Subsection 9 Benzethidine
⇒
PubChem: 62516; ChemSpider: 56290; Wikipedia: Benzethidine
3D rendering of Benzylmorphine
Benzylmorphine (3-Benzylmorphine)
CA: CDSA Schedule I Section 1 Subsection 7 Benzylmorphine
UN: Narcotics Part 1 Section 1 Benzylmorphine
US: CSA Schedule I Section c Subsection 3 Benzylmorphine
⇒
PubChem: 5362507; ChemSpider: 4515062; Wikipedia: Benzylmorphine
3D rendering of Betacetylmethadol
Betacetylmethadol
CA: CDSA Schedule I Section 6 Subsection 4 Betacetylmethadol
UN: Narcotics Part 1 Section 1 Betacetylmethadol
US: CSA Schedule I Section b Subsection 10 Betacetylmethadol
⇒
PubChem: 62710; ChemSpider: 56457; Wikipedia: Betacetylmethadol
3D rendering of Betameprodine
Betameprodine
CA: CDSA Schedule I Section 3 Subsection 5 Betameprodine
UN: Narcotics Part 1 Section 1 Betameprodine
US: CSA Schedule I Section b Subsection 13 Betameprodine
⇒
PubChem: 12218309; Wikipedia: Meprodine
3D rendering of Betamethadol
Betamethadol
CA: CDSA Schedule I Section 6 Subsection 5 Betamethadol
UN: Narcotics Part 1 Section 1 Betamethadol
US: CSA Schedule I Section b Subsection 14 Betamethadol
⇒
PubChem: 206313 10064061 62709; ChemSpider: 8239601; Wikipedia: Betamethadol
3D rendering of Betaprodine
Betaprodine
CA: CDSA Schedule I Section 3 Subsection 6 Betaprodine
UN: Narcotics Part 1 Section 1 Betaprodine
US: CSA Schedule I Section b Subsection 15 Betaprodine
⇒
PubChem: 204163 6471; ChemSpider: 4447576; Wikipedia: Prodine
3D rendering of Bezitramide
Bezitramide
CA: CDSA Schedule I Section 13 Subsection 3 Bezitramide
UN: Narcotics Part 1 Section 1 Bezitramide
US: CSA Schedule II Section c Subsection 4 Bezitramide
⇒
PubChem: 61791; ChemSpider: 55675; Wikipedia: Bezitramide
3D rendering of 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
Effective 1 May 1975, S.I. 1975/421 added:
4-Bromo-2,5-dimethoxy-α-methylphenethylamine
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
See also MDA Part I Class A Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
⇒
PubChem: 62065; ChemSpider: 55902; Bluelight: DOB; Drugs Forum: DOB; Erowid: DOB; PiHKAL • info: DOB; Wikipedia: 2,5-Dimethoxy-4-bromoamphetamine
3D rendering of Bufotenine
Bufotenine
US: CSA Schedule I Section d Subsection 17 Bufotenine
⇒
PubChem: 10257; ChemSpider: 9839; Bluelight: 5-HO-DMT; Drugs Forum: Bufotenin; Erowid: Bufotenin; TiHKAL • info: 5-HO-DMT; Wikipedia: Bufotenin
Effective 29 Jan 2004, S.I. 2003/3201 revoked:
Cannabinol, except where contained in Cannabis or Cannabis resin
UK: Currently at MDA Part II Class B Section 1(a) Cannabinol
Effective 29 Jan 2004, S.I. 2003/3201 revoked:
Cannabinol derivatives
UK: Currently at MDA Part II Class B Section 1(a) Cannabinol
3D rendering of Carfentanil
Effective 1 Apr 1987, S.I. 1986/2230 added:
Carfentanil
CA: CDSA Schedule I Section 16 Subsection 3 Carfentanil
US: CSA Schedule II Section c Subsection 6 Carfentanil
⇒
PubChem: 62156; ChemSpider: 55986; Wikipedia: Carfentanil
3D rendering of Clonitazene
Clonitazene
CA: CDSA Schedule I Section 13 Subsection 1 Clonitazene
UN: Narcotics Part 1 Section 1 Clonitazene
US: CSA Schedule I Section b Subsection 16 Clonitazene
⇒
PubChem: 62528; ChemSpider: 56301; Wikipedia: Clonitazene
Coca leaf
Part IV of the MDA says ‘“Coca leaf” means the leaf of any plant of the genus Erythroxylon from whose leaves cocaine can be extracted either directly or by chemical transformation.’
CA: CDSA Schedule I Section 2 Subsection 1 Coca leaves
UN: Narcotics Part 1 Section 1 Coca leaf
US: CSA Schedule II Section b Subsection 4 Coca leaves
⇒
Drugs Forum: Coca; Erowid: Coca; Wikipedia: Coca
3D rendering of Cocaine
Cocaine
CA: CDSA Schedule I Section 2 Subsection 2 Cocaine
UN: Narcotics Part 1 Section 1 Cocaine and Part 2 Section 4 Cocaine
US: CSA Schedule II Section b Subsection 4 Cocaine
⇒
PubChem: 5760; ChemSpider: 4475153; Bluelight: Cocaine; Drugs Forum: Cocaine; Erowid: Cocaine; Wikipedia: Cocaine
3D rendering of 4-Cyano-2-dimethylamino-4,4-diphenylbutane
4-Cyano-2-dimethylamino-4,4-diphenylbutane
CA: CDSA Schedule I Section 5 Subsection 1 Dimethylaminodiphenylbutanonitrile
UN: Narcotics Part 1 Section 1 Methadone intermediate
US: CSA Schedule II Section c Subsection 16 Methadone-intermediate
⇒
PubChem: 31331; ChemSpider: 29065
3D rendering of 4-Cyano-1-methyl-4-phenylpiperidine
4-Cyano-1-methyl-4-phenylpiperidine
CA: CDSA Schedule I Section 3 Subsection 14 Methylphenylisonipecotonitrile
UN: Narcotics Part 1 Section 1 Pethidine intermediate A
US: CSA Schedule II Section c Subsection 19 Pethidine-intermediate-A
⇒
PubChem: 62513; ChemSpider: 56289; Erowid: Pethidine ; Wikipedia: Pethidine intermediate A
3D rendering of 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine
Effective 11 Mar 2015, S.I. 2015/215 added:
On 17 Dec 2014, S.I. 2015/215* proposed to add:
1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)
⇒
PubChem: 431865; ChemSpider: 381935; Wikipedia: MT-45
3D rendering of 3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)
The systematic name given in the amendment, were it strictly following the rules, would employ braces {or ‘curly brackets’} as the outermost enclosing marks. See IUPAC. Nomenenclature of Organic Chemistry, Royal Society of Chemistry, 2013. See P-16.5 Enclosing Marks, p. 113.
EU: Substances Substances 3,4-Dichloro-N-[[1-dimethylamino) cyclohexyl]methyl] benzamide
⇒
PubChem: 187760; ChemSpider: 163208; Bluelight: AH-7921; Wikipedia: AH-7921
3D rendering of (6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
(6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
(6aR,9R)-N,N-Diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[5,4,3-fg]quinoline-9-carboxamide (AL-LAD)
The systematic name given in the original, withdrawn amendment is wrong in two ways, one of them fatal. It does not describe the intended substance, nor any other known or possible structure. The amended version fixes the fatal mistake but, strictly speaking, is still wrong.
3D rendering of (6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
(6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
(6aR,9R)-N,N-Diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[5,4,3-fg]quinoline-9-carboxamide (ETH-LAD)
The systematic name given in the original, withdrawn amendment is wrong in two ways, one of them fatal. It does not describe the intended substance, nor any other known or possible structure. The amended version fixes the fatal mistake but, strictly speaking, is still wrong.
3D rendering of (6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
(6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
(6aR,9R)-N,N-Diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[5,4,3-fg]quinoline-9-carboxamide (PRO-LAD)
The systematic name given in the original, withdrawn amendment is fatally wrong. It does not describe the intended substance, nor any other known or possible structure. The systematic name given in the amended version—and I caution you this is only my most guarded, inexpert opinion—appears correct. Very good!
3D rendering of Desomorphine
Desomorphine
CA: CDSA Schedule I Section 1 Subsection 9 Desomorphine
UN: Narcotics Part 1 Section 1 Desomorphine and Section 3 Desomorphine
US: CSA Schedule I Section c Subsection 7 Desomorphine
⇒
PubChem: 5362456; ChemSpider: 4515044; Erowid: Desomorphine; Wikipedia: Desomorphine
3D rendering of Dextromoramide
Dextromoramide
CA: CDSA Schedule I Section 9 Subsection 1 Dextromoramide
UN: Narcotics Part 1 Section 1 Dextromoramide
US: CSA Schedule I Section b Subsection 17 Dextromoramide
⇒
PubChem: 92943; ChemSpider: 83901; Wikipedia: Dextromoramide
3D rendering of Diamorphine
Diamorphine
CA: CDSA Schedule I Section 1 Subsection 10 Diacetylmorphine
UN: Narcotics Part 1 Section 1 Heroin and Section 3 Heroin
US: CSA Schedule I Section c Subsection 11 Heroin
⇒
PubChem: 5462328; ChemSpider: 4575379; Bluelight: Heroin; Drugs Forum: Heroin; Erowid: Heroin; Wikipedia: Heroin
3D rendering of Diampromide
Diampromide
CA: CDSA Schedule I Section 12 Subsection 1 Diampromide
UN: Narcotics Part 1 Section 1 Diampromide
US: CSA Schedule I Section b Subsection 18 Diampromide
⇒
PubChem: 62370; ChemSpider: 56158; Wikipedia: Diampromide
3D rendering of Diethylthiambutene
Diethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 1 Diethylthiambutene
UN: Narcotics Part 1 Section 1 Diethylthiambutene
US: CSA Schedule I Section b Subsection 19 Diethylthiambutene
⇒
PubChem: 6833; ChemSpider: 6572; Wikipedia: Diethylthiambutene
3D rendering of N,N-Diethyltryptamine
N,N-Diethyltryptamine
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
US: CSA Schedule I Section d Subsection 18 Diethyltryptamine
⇒
PubChem: 6090; ChemSpider: 5865; Erowid: DET; TiHKAL • info: DET; Wikipedia: Diethyltryptamine
3D rendering of 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ)
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[5,4,3-fg]quinolin-9-yl}methanone (LSZ)
The systematic name given in the original, withdrawn amendment is wrong in two ways, one of them fatal. It does not describe the intended substance, nor any other known or possible structure. The amended version fixes the fatal mistake but, strictly speaking, were it following the rules, would employ square brackets, not braces {‘curly brackets’} as the outermost enclosing marks. See IUPAC. Nomenenclature of Organic Chemistry, Royal Society of Chemistry, 2013. See P-16.5 Enclosing Marks, p. 113.
3D rendering of Difenoxin
Effective 1 May 1975, S.I. 1975/421 added:
Difenoxin (1-[3-Cyano-3,3-diphenylpropyl]-4-phenylpiperidine-4-carboxylic acid)
CA: CDSA Schedule I Section 3 Subsection 9 Difenoxin
UN: Narcotics Part 1 Section 1 Difenoxin and Part 2 Section 5 Difenoxin
US: CSA Schedule I Section b Subsection 20 Difenoxin, Schedule IV Section b Subsection 1 Difenoxin and Schedule V Section c Subsection 6 Difenoxin
⇒
PubChem: 34328; ChemSpider: 31620; Wikipedia: Difenoxin
3D rendering of Dihydrocodeinone O-carboxymethyloxime
Dihydrocodeinone O-carboxymethyloxime
CA: CDSA Schedule I Section 1 Subsection 8 Codoxime
UN: Narcotics Part 1 Section 1 Codoxime
⇒
PubChem: 5360238; ChemSpider: 7844721; Wikipedia: Codoxime
3D rendering of Dihydroetorphine
Effective 1 Jul 2003, S.I. 2003/1243 added:
Dihydroetorphine
UN: Narcotics Part 1 Section 1 Dihydroetorphine
US: CSA Schedule II Section b Subsection 1 Item ii Dihydroetorphine
⇒
PubChem: 107765; ChemSpider: 96924; Wikipedia: Dihydroetorphine
3D rendering of Dihydromorphine
Dihydromorphine
CA: CDSA Schedule I Section 1 Subsection 12 Dihydromorphine
UN: Narcotics Part 1 Section 1 Dihydromorphine
US: CSA Schedule I Section c Subsection 8 Dihydromorphine
⇒
PubChem: 5359421; ChemSpider: 4514282; Wikipedia: Dihydromorphine
3D rendering of Dimenoxadole
Dimenoxadole
CA: CDSA Schedule I Section 7 Subsection 1 Dimenoxadol
UN: Narcotics Part 1 Section 1 Dimenoxadol
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
⇒
PubChem: 17036; ChemSpider: 16137; Wikipedia: Dimenoxadol
3D rendering of Dimepheptanol
Dimepheptanol
CA: CDSA Schedule I Section 6 Subsection 6 Dimepheptanol
UN: Narcotics Part 1 Section 1 Dimepheptanol
US: CSA Schedule I Section b Subsection 22 Dimepheptanol
⇒
PubChem: 28397; ChemSpider: 26418; Wikipedia: Dimepheptanol
3D rendering of Dimethylthiambutene
Dimethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 2 Dimethylthiambutene
UN: Narcotics Part 1 Section 1 Dimethylthiambutene
US: CSA Schedule I Section b Subsection 23 Dimethylthiambutene
⇒
PubChem: 10668; ChemSpider: 10218; Wikipedia: Dimethylthiambutene
3D rendering of N,N-Dimethyltryptamine
N,N-Dimethyltryptamine
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
US: CSA Schedule I Section d Subsection 19 Dimethyltryptamine
⇒
PubChem: 6089; ChemSpider: 5864; Bluelight: DMT; Drugs Forum: DMT; Erowid: DMT; TiHKAL • info: DMT; Wikipedia: Dimethyltryptamine
3D rendering of 2,5-Dimethoxy-α,4-dimethylphenethylamine
2,5-Dimethoxy-α,4-dimethylphenethylamine
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
See also MDA Part I Class A Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
⇒
PubChem: 85875; ChemSpider: 77462; Bluelight: DOM; Drugs Forum: DOM; Erowid: STP; PiHKAL • info: DOM; Wikipedia: 2,5-Dimethoxy-4-methylamphetamine
3D rendering of Dioxaphetyl butyrate
Dioxaphetyl butyrate
CA: CDSA Schedule I Section 7 Subsection 2 Dioxaphetyl butyrate
UN: Narcotics Part 1 Section 1 Dioxaphetyl butyrate
US: CSA Schedule I Section b Subsection 24 Dioxaphetyl butyrate
⇒
PubChem: 48194; ChemSpider: 43838; Wikipedia: Dioxaphetyl butyrate
3D rendering of Diphenoxylate
Diphenoxylate
CA: CDSA Schedule I Section 3 Subsection 8 Diphenoxylate
UN: Narcotics Part 1 Section 1 Diphenoxylate and Part 2 Section 6 Diphenoxylate
US: CSA Schedule II Section c Subsection 8 Diphenoxylate and Schedule V Section c Subsection 4 Diphenoxylate
⇒
PubChem: 13505; ChemSpider: 12919; Wikipedia: Diphenoxylate
3D rendering of Dipipanone
Dipipanone
CA: CDSA Schedule I Section 5 Subsection 2 Dipipanone
UN: Narcotics Part 1 Section 1 Dipipanone
US: CSA Schedule I Section b Subsection 25 Dipipanone
⇒
PubChem: 13331; ChemSpider: 12766; Wikipedia: Dipipanone
3D rendering of Drotebanol
Effective 1 Jul 1973, S.I. 1973/771 added:
Drotebanol (3,4-Dimethoxy-17-methylmorphinan-6β,14-diol)
CA: CDSA Schedule I Section 10 Subsection 2 Drotebanol
UN: Narcotics Part 1 Section 1 Drotebanol
US: CSA Schedule I Section c Subsection 9 Drotebanol
⇒
PubChem: 5463863; ChemSpider: 16736125; Wikipedia: Drotebanol
3D rendering of Ecgonine
Ecgonine and any derivative of Ecgonine which is convertible to Ecgonine or to Cocaine
CA: CDSA Schedule I Section 2 Subsection 3 Ecgonine
UN: Narcotics Part 1 Section 1 Ecgonine
US: CSA Schedule II Section b Subsection 4 Ecgonine
⇒
PubChem: 91460; ChemSpider: 4475941; Wikipedia: Ecgonine
3D rendering of Ethylmethylthiambutene
Ethylmethylthiambutene
CA: CDSA Schedule I Section 8 Subsection 3 Ethylmethylthiambutene
UN: Narcotics Part 1 Section 1 Ethylmethylthiambutene
US: CSA Schedule I Section b Subsection 26 Ethylmethylthiambutene
⇒
PubChem: 46424; ChemSpider: 42256; Wikipedia: Ethylmethylthiambutene
3D rendering of Eticyclidine
Effective 1 Jan 1985, S.I. 1984/859 added:
Eticyclidine
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UN: Psychotropics Schedule I Eticyclidine (PCE)
US: CSA Schedule I Section d Subsection 32 Ethylamine analog of Phencyclidine
⇒
PubChem: 16622; ChemSpider: 15759; Wikipedia: Eticyclidine
3D rendering of Etonitazene
Etonitazene
CA: CDSA Schedule I Section 13 Subsection 2 Etonitazene
UN: Narcotics Part 1 Section 1 Etonitazene
US: CSA Schedule I Section b Subsection 27 Etonitazene
⇒
PubChem: 13493; ChemSpider: 12908; Wikipedia: Etonitazene
3D rendering of Etorphine
Etorphine
CA: CDSA Schedule I Section 1 Subsection 14 Etorphine
UN: Narcotics Part 1 Section 1 Etorphine and Section 3 Etorphine
US: CSA Schedule I Section c Subsection 10 Etorphine
⇒
PubChem: 644209; ChemSpider: 559231; Wikipedia: Etorphine
3D rendering of Etoxeridine
Etoxeridine
CA: CDSA Schedule I Section 3 Subsection 10 Etoxeridine
UN: Narcotics Part 1 Section 1 Etoxeridine
US: CSA Schedule I Section b Subsection 28 Etoxeridine
⇒
PubChem: 61122; ChemSpider: 55070; Wikipedia: Etoxeridine
3D rendering of Etryptamine
Effective 1 May 1998, S.I. 1998/750 added:
Etryptamine
CA: CDSA Schedule III Section 28 Etryptamine
UN: Psychotropics Schedule I Etryptamine
US: CSA Schedule I Section d Subsection 1 Alpha-ethyltryptamine
⇒
PubChem: 8367; ChemSpider: 8064; Bluelight: AET; Erowid: AET; TiHKAL • info: α-ET; Wikipedia: alpha-Ethyltryptamine
3D rendering of Fentanyl
Fentanyl
CA: CDSA Schedule I Section 16 Subsection 5 Fentanyl
UN: Narcotics Part 1 Section 1 Fentanyl
US: CSA Schedule II Section c Subsection 9 Fentanyl
⇒
PubChem: 3345; ChemSpider: 3228; Drugs Forum: Fentanyl; Erowid: Fentanyl; Wikipedia: Fentanyl
CA: CDSA Schedule I Section 16 Fentanyls
See also MDA Part I Class A Section 1(d) Fentanyl
Effective 18 Jul 2005, 2005 c. 17 added:
Fungus (of any kind) which contains Psilocin or an ester of Psilocin
⇒
Drugs Forum: Magic Mushrooms; Wikipedia: Fungus
CA: CDSA Schedule III Section 11 Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
See also MDA Part I Class A Section 1(a) Psilocin
⇒
PubChem: 4980; ChemSpider: 4807; Bluelight: 4-HO-DMT; Drugs Forum: 4-HO-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-HO-DMT; Wikipedia: Psilocin
3D rendering of Furethidine
Furethidine
CA: CDSA Schedule I Section 3 Subsection 11 Furethidine
UN: Narcotics Part 1 Section 1 Furethidine
US: CSA Schedule I Section b Subsection 29 Furethidine
⇒
PubChem: 61306; ChemSpider: 55245; Wikipedia: Furethidine
3D rendering of Hydrocodone
Hydrocodone
CA: CDSA Schedule I Section 1 Subsection 15 Hydrocodone
UN: Narcotics Part 1 Section 1 Hydrocodone
US: CSA Schedule II Section b Subsection 1 Item vi Hydrocodone
US: [revoked] CSA Schedule III Section e Subsection 1 Dihydrocodeinone and Dihydrocodeinone
⇒
PubChem: 5284569; ChemSpider: 4447623; Drugs Forum: Hydrocodone; Erowid: Hydrocodone; Wikipedia: Hydrocodone
3D rendering of Hydromorphinol
Hydromorphinol
CA: CDSA Schedule I Section 1 Subsection 16 Hydromorphinol
UN: Narcotics Part 1 Section 1 Hydromorphinol
US: CSA Schedule I Section c Subsection 12 Hydromorphinol
⇒
PubChem: 5463858; ChemSpider: 4576407; Wikipedia: Hydromorphinol
3D rendering of Hydromorphone
Hydromorphone
CA: CDSA Schedule I Section 1 Subsection 17 Hydromorphone
UN: Narcotics Part 1 Section 1 Hydromorphone
US: CSA Schedule II Section b Subsection 1 Item vii Hydromorphone
⇒
PubChem: 5284570; ChemSpider: 4447624; Drugs Forum: Hydromorphone; Erowid: Hydromorphone; Wikipedia: Hydromorphone
3D rendering of Hydroxypethidine
Hydroxypethidine
CA: CDSA Schedule I Section 3 Subsection 12 Hydroxypethidine
UN: Narcotics Part 1 Section 1 Hydroxypethidine
US: CSA Schedule I Section b Subsection 30 Hydroxypethidine
⇒
PubChem: 61120; ChemSpider: 55068; Wikipedia: Hydroxypethidine
3D rendering of N-Hydroxy-tenamphetamine
Effective 1 Feb 1990, S.I. 1990/2589 added:
N-Hydroxy-tenamphetamine
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
See also MDA Part I Class A Section 1(f) N-Hydroxytenamphetamine
⇒
PubChem: 98528; ChemSpider: 88979; PiHKAL • info: MDOH; Wikipedia: MDOH
3D rendering of Isomethadone
Isomethadone
CA: CDSA Schedule I Section 5 Subsection 3 Isomethadone
UN: Narcotics Part 1 Section 1 Isomethadone
US: CSA Schedule II Section c Subsection 10 Isomethadone
⇒
PubChem: 10072; ChemSpider: 9675; Wikipedia: Isomethadone
3D rendering of Ketobemidone
Ketobemidone
CA: CDSA Schedule I Section 3 Subsection 13 Ketobemidone
UN: Narcotics Part 1 Section 1 Ketobemidone and Section 3 Ketobemidone
US: CSA Schedule I Section b Subsection 31 Ketobemidone
⇒
PubChem: 10101; ChemSpider: 9697; Drugs Forum: Ketobemidone; Wikipedia: Ketobemidone
3D rendering of Levomethorphan
Levomethorphan
Section 2 specifically excludes Dextromethorphan (a stereoisomer of Levomethorphan) from this Schedule.
CA: CDSA Schedule I Section 10 Subsection 3 Levomethorphan
UN: Narcotics Part 1 Section 1 Levomethorphan
US: CSA Schedule II Section c Subsection 12 Levomethorphan
⇒
PubChem: 5362449; ChemSpider: 4642423; Bluelight: Levomethorphan; Drugs Forum: Levomethorphan; Wikipedia: Levomethorphan
3D rendering of Levomoramide
Levomoramide
CA: CDSA Schedule I Section 9 Subsection 3 Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
⇒
PubChem: 10453145; ChemSpider: 8628561; Wikipedia: Levomoramide
3D rendering of Levophenacylmorphan
Levophenacylmorphan
CA: CDSA Schedule I Section 10 Subsection 5 Levophenacylmorphan
UN: Narcotics Part 1 Section 1 Levophenacylmorphan
US: CSA Schedule I Section b Subsection 33 Levophenacylmorphan
⇒
PubChem: 5362482; ChemSpider: 16736786; Wikipedia: Levophenacylmorphan
3D rendering of Levorphanol
Levorphanol
Section 2 specifically excludes Dextrorphan (a stereoisomer of Levorphanol) from this Schedule.
CA: CDSA Schedule I Section 10 Subsection 4 Levorphanol
UN: Narcotics Part 1 Section 1 Levorphanol
US: CSA Schedule II Section c Subsection 13 Levorphanol
⇒
PubChem: 5359272; ChemSpider: 16736212; Bluelight: Levorphanol ; Drugs Forum: Levorphanol ; Erowid: Levorphanol Synthesis; Wikipedia: Levorphanol
3D rendering of Lofentanil
Effective 1 Apr 1987, S.I. 1986/2230 added:
Lofentanil
⇒
PubChem: 123642 65499; ChemSpider: 110226; Wikipedia: Lofentanil
3D rendering of Lysergamide
Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
⇒
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
3D rendering of Lysergide
Lysergide and other N-alkyl derivatives of Lysergamide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
3D rendering of Mescaline
Mescaline
CA: CDSA Schedule III Section 17 Mescaline
UN: Psychotropics Schedule I Mescaline
US: CSA Schedule I Section d Subsection 24 Mescaline
See also MDA Part I Class A Section 1(f) Mescaline
⇒
PubChem: 4076; ChemSpider: 3934; Drugs Forum: Mescaline; Erowid: Mescaline; PiHKAL • info: M; Wikipedia: Mescaline
3D rendering of Metazocine
Metazocine
CA: CDSA Schedule I Section 11 Subsection 2 Metazocine
UN: Narcotics Part 1 Section 1 Metazocine and Psychotropics Schedule III Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
See also MDA Part II Class B Section 1(a) Metazocine
⇒
PubChem: 3037886; ChemSpider: 391630; Wikipedia: Metazocine
3D rendering of Methadone
Methadone
CA: CDSA Schedule I Section 5 Subsection 4 Methadone
UN: Narcotics Part 1 Section 1 Methadone
US: CSA Schedule II Section c Subsection 15 Methadone
⇒
PubChem: 4095; ChemSpider: 3953; Bluelight: Methadone; Drugs Forum: Methadone; Erowid: Methadone; Wikipedia: Methadone
3D rendering of Methadyl acetate
Methadyl acetate
CA: CDSA Schedule I Section 6 Subsection 1 Acetylmethadol
UN: Narcotics Part 1 Section 1 Acetylmethadol
US: CSA Schedule I Section b Subsection 2 Acetylmethadol
⇒
PubChem: 10517; ChemSpider: 10080; Wikipedia: Acetylmethadol
3D rendering of Methylamphetamine
Effective 18 Jan 2007, S.I. 2006/3331 added:
Methylamphetamine
CA: CDSA Schedule I Section 18 Methamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 23 Methamphetamine
UN: Psychotropics Schedule II Metamfetamine racemate (Methamphetamine racemate)
US: CSA Schedule II Section d Subsection 2 Methamphetamine
UK: Previously at MDA Part II Class B Section 1(a)
⇒
PubChem: 1206; ChemSpider: 1169; Bluelight: Methamphetamine; Drugs Forum: Methamphetamine; Erowid: Meth; Wikipedia: Methamphetamine
3D rendering of 4-Methyl-aminorex
Effective 1 Feb 1990, S.I. 1990/2589 added:
4-Methyl-aminorex
CA: CDSA Schedule III Section 18 4-Methylaminorex
UN: Psychotropics Schedule I 4-Methylaminorex
US: CSA Schedule I Section f Subsection 6 (±)-cis-4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
3D rendering of 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine
Effective 11 Mar 2015, S.I. 2015/215 added:
On 17 Dec 2014, S.I. 2015/215* proposed to add:
4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4ʹ-DMAR)
⇒
PubChem: 20741615; Wikipedia: 4,4%27-Dimethylaminorex
3D rendering of Methyldesorphine
Methyldesorphine
CA: CDSA Schedule I Section 1 Subsection 18 Methyldesorphine
UN: Narcotics Part 1 Section 1 Methyldesorphine
US: CSA Schedule I Section c Subsection 13 Methyldesorphine
⇒
PubChem: 5362518; ChemSpider: 4515065; Wikipedia: Methyldesorphine
3D rendering of Methyldihydromorphine
Methyldihydromorphine (6-Methyldihydromorphine)
CA: CDSA Schedule I Section 1 Subsection 19 Methyldihydromorphine
UN: Narcotics Part 1 Section 1 Methyldihydromorphine
US: CSA Schedule I Section c Subsection 14 Methyldihydromorphine
⇒
PubChem: 5464303; ChemSpider: 4576611; Wikipedia: Methyldihydromorphine
3D rendering of 2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
CA: CDSA Schedule I Section 9 Subsection 2 Diphenylmorpholinoisovaleric acid
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
⇒
PubChem: 567581; ChemSpider: 493453; Wikipedia: Moramide intermediate
3D rendering of 1-Methyl-4-phenylpiperidine-4-carboxylic acid
1-Methyl-4-phenylpiperidine-4-carboxylic acid
CA: CDSA Schedule I Section 3 Subsection 22 Pethidine intermediate C
UN: Narcotics Part 1 Section 1 Pethidine intermediate C
US: CSA Schedule II Section c Subsection 21 Pethidine-intermediate-C
⇒
PubChem: 101106; ChemSpider: 91344; Erowid: Pethidinic acid; Wikipedia: Pethidinic acid
3D rendering of Metopon
Metopon
CA: CDSA Schedule I Section 1 Subsection 20 Metopon
UN: Narcotics Part 1 Section 1 Metopon
US: CSA Schedule II Section b Subsection 1 Item viii Metopon
⇒
PubChem: 5359353; ChemSpider: 4514264; Wikipedia: Metopon
3D rendering of Morpheridine
Morpheridine
CA: CDSA Schedule I Section 3 Subsection 15 Morpheridine
UN: Narcotics Part 1 Section 1 Morpheridine
US: CSA Schedule I Section b Subsection 36 Morpheridine
⇒
PubChem: 61121; ChemSpider: 55069; Wikipedia: Morpheridine
3D rendering of Morphine
Morphine
CA: CDSA Schedule I Section 1 Subsection 3 Morphine
UN: Narcotics Part 1 Section 1 Morphine and Part 2 Section 4 Morphine
US: CSA Schedule II Section b Subsection 1 Item ix Morphine and Schedule III Section e Subsection 1 Item vi Morphine
⇒
PubChem: 5288826; ChemSpider: 4450907; Bluelight: Morphine; Drugs Forum: Morphine; Erowid: Morphine; Wikipedia: Morphine
3D rendering of Morphine methobromide
Morphine methobromide
3D rendering of Morphine N-oxide
Morphine N-oxide
Morphine methobromide, Morphine N-oxide and other pentavalent nitrogen Morphine derivatives
UN: Narcotics Part 1 Section 1 Morphine methobromide
US: CSA Schedule I Section c Subsection 15 Morphine methobromide
⇒
PubChem: 5362445; ChemSpider: 16788217; Wikipedia: Morphine methylbromide
CA: CDSA Schedule I Section 1 Subsection 21 Morphine-N-oxide
UN: Narcotics Part 1 Section 1 Morphine-N-oxide
US: CSA Schedule I Section c Subsection 17 Morphine-N-oxide
⇒
PubChem: 5362459; ChemSpider: 4515047; Wikipedia: Morphine-N-oxide
3D rendering of Myrophine
Myrophine
CA: CDSA Schedule I Section 1 Subsection 22 Myrophine
UN: Narcotics Part 1 Section 1 Myrophine
US: CSA Schedule I Section c Subsection 18 Myrophine
⇒
PubChem: 5362457; ChemSpider: 4515045; Wikipedia: Myrophine
Effective 1 Jul 1973, S.I. 1973/771 revoked:
Nicodicodine (6-Nicotinoyldihydrocodeine)
UK: Currently at MDA Part II Class B Section 1(a) Nicodicodine
3D rendering of Nicomorphine
Nicomorphine (3,6-Dinicotinoylmorphine)
CA: CDSA Schedule I Section 1 Subsection 25 Nicomorphine
UN: Narcotics Part 1 Section 1 Nicomorphine
US: CSA Schedule I Section c Subsection 20 Nicomorphine
⇒
PubChem: 5362460; ChemSpider: 4515048; Drugs Forum: Nicomorphine; Wikipedia: Nicomorphine
3D rendering of Noracymethadol
Noracymethadol
CA: CDSA Schedule I Section 6 Subsection 7 Noracymethadol
UN: Narcotics Part 1 Section 1 Noracymethadol
US: CSA Schedule I Section b Subsection 38 Noracymethadol
⇒
PubChem: 15129; ChemSpider: 14400; Wikipedia: Noracymethadol
3D rendering of Norlevorphanol
Norlevorphanol
CA: CDSA Schedule I Section 10 Subsection 6 Norlevorphanol
UN: Narcotics Part 1 Section 1 Norlevorphanol
US: CSA Schedule I Section b Subsection 39 Norlevorphanol
⇒
PubChem: 5463854; ChemSpider: 16735936; Wikipedia: Norlevorphanol
3D rendering of Normethadone
Normethadone
CA: CDSA Schedule I Section 5 Subsection 5 Normethadone
UN: Narcotics Part 1 Section 1 Normethadone
US: CSA Schedule I Section b Subsection 40 Normethadone
⇒
PubChem: 10090; ChemSpider: 9687; Wikipedia: Normethadone
3D rendering of Normorphine
Normorphine
CA: CDSA Schedule I Section 1 Subsection 27 Normorphine
UN: Narcotics Part 1 Section 1 Normorphine
US: CSA Schedule I Section c Subsection 21 Normorphine
⇒
PubChem: 430245; ChemSpider: 4575435; Bluelight: Normorphine; Wikipedia: Normorphine
3D rendering of Norpipanone
Norpipanone
CA: CDSA Schedule I Section 5 Subsection 6 Norpipanone
UN: Narcotics Part 1 Section 1 Norpipanone
US: CSA Schedule I Section b Subsection 41 Norpipanone
⇒
PubChem: 22391; ChemSpider: 21015; Wikipedia: Norpipanone
Opium, whether raw, prepared or medicinal
Part IV of the MDA says ‘“Raw opium” includes powdered or granulated opium but does not include medicinal opium.’
Part IV of the MDA says ‘“Medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances.’
CA: CDSA Schedule I Section 1 Subsection 1 Opium
UN: Narcotics Part 1 Section 1 Opium, Part 2 Section 4 Opium and Section 7 Opium
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
⇒
PubChem: 167253 202889 202890 17397953 17397584 3842991 202886 202888 413265 3730541; Drugs Forum: Opium; Wikipedia: Opium
3D rendering of Oxycodone
Oxycodone
CA: CDSA Schedule I Section 1 Subsection 28 Oxycodone
UN: Narcotics Part 1 Section 1 Oxycodone
US: CSA Schedule II Section b Subsection 1 Item xiii Oxycodone
⇒
PubChem: 5284603; ChemSpider: 4447649; Bluelight: Oxycodone; Drugs Forum: Oxycodone; Erowid: Oxycodone; Wikipedia: Oxycodone
3D rendering of Oxymorphone
Oxymorphone
CA: CDSA Schedule I Section 1 Subsection 29 Oxymorphone
UN: Narcotics Part 1 Section 1 Oxymorphone
US: CSA Schedule II Section b Subsection 1 Item xiv Oxymorphone
⇒
PubChem: 5284604; ChemSpider: 4447650; Bluelight: Oxymorphone; Drugs Forum: Oxymorphone; Erowid: Oxymorphone; Wikipedia: Oxymorphone
3D rendering of Pethidine
Pethidine
CA: CDSA Schedule I Section 3 Subsection 17 Pethidine
UN: Narcotics Part 1 Section 1 Pethidine
US: CSA Schedule II Section c Subsection 18 Pethidine
⇒
PubChem: 4058; ChemSpider: 3918; Erowid: Meperidine; Wikipedia: Pethidine
CA: CDSA Schedule I Section 3 Phenylpiperidines
See also MDA Part I Class A Section 1(e) Pethidine [derivatives]
3D rendering of Phenadoxone
Phenadoxone
CA: CDSA Schedule I Section 5 Subsection 7 Phenadoxone
UN: Narcotics Part 1 Section 1 Phenadoxone
US: CSA Schedule I Section b Subsection 44 Phenadoxone
⇒
PubChem: 10089; ChemSpider: 9686; Wikipedia: Phenadoxone
3D rendering of Phenampromide
Phenampromide
CA: CDSA Schedule I Section 12 Subsection 2 Phenampromide
UN: Narcotics Part 1 Section 1 Phenampromide
US: CSA Schedule I Section b Subsection 45 Phenampromide
⇒
PubChem: 8523; ChemSpider: 8209; Wikipedia: Phenampromide
3D rendering of Phenazocine
Phenazocine
CA: CDSA Schedule I Section 11 Subsection 1 Phenazocine
UN: Narcotics Part 1 Section 1 Phenazocine
US: CSA Schedule II Section c Subsection 22 Phenazocine
⇒
PubChem: 14707; ChemSpider: 391631; Drugs Forum: Phenazocine; Wikipedia: Phenazocine
3D rendering of Phencyclidine
Effective 14 May 1979, S.I. 1979/299 added:
Phencyclidine
CA: CDSA Schedule I Section 14 Phencyclidine
UN: Psychotropics Schedule II Phencyclidine (PCP)
US: CSA Schedule II Section e Subsection 4 Phencyclidine
⇒
PubChem: 6468; ChemSpider: 6224; Bluelight: PCP; Drugs Forum: Phencyclidine; Erowid: PCP; Wikipedia: Phencyclidine
3D rendering of Phenomorphan
Phenomorphan
CA: CDSA Schedule I Section 10 Subsection 7 Phenomorphan
UN: Narcotics Part 1 Section 1 Phenomorphan
US: CSA Schedule I Section b Subsection 46 Phenomorphan
⇒
PubChem: 5362458; ChemSpider: 16735962; Wikipedia: Phenomorphan
3D rendering of Phenoperidine
Phenoperidine
CA: CDSA Schedule I Section 3 Subsection 18 Phenoperidine
UN: Narcotics Part 1 Section 1 Phenoperidine
US: CSA Schedule I Section b Subsection 47 Phenoperidine
⇒
PubChem: 11226; ChemSpider: 10752; Wikipedia: Phenoperidine
3D rendering of 4-Phenylpiperidine-4-carboxylic acid ethyl ester
4-Phenylpiperidine-4-carboxylic acid ethyl ester
CA: CDSA Schedule I Section 3 Subsection 16 Norpethidine
UN: Narcotics Part 1 Section 1 Pethidine intermediate B
US: CSA Schedule II Section c Subsection 20 Pethidine-intermediate-B
⇒
PubChem: 32414; ChemSpider: 30039; Erowid: Norpethidine; Wikipedia: Norpethidine
3D rendering of Piminodine
Piminodine
CA: CDSA Schedule I Section 3 Subsection 19 Piminodine
UN: Narcotics Part 1 Section 1 Piminodine
US: CSA Schedule II Section c Subsection 23 Piminodine
⇒
PubChem: 21950; ChemSpider: 20628; Wikipedia: Piminodine
3D rendering of Piritramide
Piritramide
CA: CDSA Schedule I Section 15 Piritramide
UN: Narcotics Part 1 Section 1 Piritramide
US: CSA Schedule I Section b Subsection 48 Piritramide
⇒
PubChem: 9331; ChemSpider: 8967; Drugs Forum: Piritramide; Wikipedia: Piritramide

Poppy-straw and Concentrate of poppy-straw
Part IV of the MDA says ‘“Poppy-straw” means all parts, except the seeds, of the opium poppy, after mowing.’
Part IV of the MDA says ‘“Concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids.’
Part IV of the MDA says ‘“Opium poppy” means the plant of species Papaver somniferum L.’
US: CSA Schedule II Section b Subsection 3 Poppy straw
⇒
PubChem: 160615 53477776; Wikipedia: Poppy straw
UN: Narcotics Part 1 Section 1 Concentrate of poppy straw
US: CSA Schedule II Section b Subsection 5 Concentrate of poppy straw
⇒
PubChem: 9813907 6602144 33741
3D rendering of Proheptazine
Proheptazine
CA: CDSA Schedule I Section 4 Subsection 1 Proheptazine
UN: Narcotics Part 1 Section 1 Proheptazine
US: CSA Schedule I Section b Subsection 49 Proheptazine
⇒
PubChem: 60969; ChemSpider: 54931; Wikipedia: Proheptazine
3D rendering of Properidine
Properidine (1-Methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester)
CA: CDSA Schedule I Section 3 Subsection 20 Properidine
UN: Narcotics Part 1 Section 1 Properidine
US: CSA Schedule I Section b Subsection 50 Properidine
⇒
PubChem: 62373; ChemSpider: 56161; Wikipedia: Properidine
3D rendering of Psilocin
Psilocin
CA: CDSA Schedule III Section 11 Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
US: CSA Schedule I Section d Subsection 30 Psilocyn
⇒
PubChem: 4980; ChemSpider: 4807; Bluelight: 4-HO-DMT; Drugs Forum: 4-HO-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-HO-DMT; Wikipedia: Psilocin
See also MDA Part I Class A Section 1(a) Fungus
⇒
Drugs Forum: Magic Mushrooms; Wikipedia: Fungus
3D rendering of Racemethorphan
Racemethorphan
CA: CDSA Schedule I Section 10 Subsection 8 Racemethorphan
UN: Narcotics Part 1 Section 1 Racemethorphan
US: CSA Schedule II Section c Subsection 24 Racemethorphan
⇒
PubChem: 3008 5359423; ChemSpider: 2901; Wikipedia: Methorphan
3D rendering of Racemoramide
Racemoramide
CA: CDSA Schedule I Section 9 Subsection 4 Racemoramide
UN: Narcotics Part 1 Section 1 Racemoramide
US: CSA Schedule I Section b Subsection 52 Racemoramide
⇒
PubChem: 9648; ChemSpider: 9269; Wikipedia: Racemoramide
3D rendering of Racemorphan
Racemorphan
CA: CDSA Schedule I Section 10 Subsection 9 Racemorphan
UN: Narcotics Part 1 Section 1 Racemorphan
US: CSA Schedule II Section c Subsection 25 Racemorphan
⇒
PubChem: 3918 5359272; ChemSpider: 3781; Erowid: Racemorphan ; Wikipedia: Morphanol
3D rendering of Remifentanil
Effective 1 Jul 2003, S.I. 2003/1243 added:
Remifentanil
CA: CDSA Schedule I Section 16 Subsection 11.1 Remifentanil
UN: Narcotics Part 1 Section 1 Remifentanil
US: CSA Schedule II Section c Subsection 26 Remifentanil
⇒
PubChem: 60815; ChemSpider: 54803; Drugs Forum: Remifentanil; Wikipedia: Remifentanil
3D rendering of Rolicyclidine
Effective 1 Jan 1985, S.I. 1984/859 added:
Rolicyclidine
CA: CDSA Schedule III Section 16 Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
US: CSA Schedule I Section d Subsection 33 Pyrrolidine analog of Phencyclidine
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
3D rendering of Sufentanil
Effective 18 Jul 1983, S.I. 1983/765 added:
Sufentanil
CA: CDSA Schedule I Section 16 Subsection 12 Sufentanil
UN: Narcotics Part 1 Section 1 Sufentanil
US: CSA Schedule II Section c Subsection 27 Sufentanil
⇒
PubChem: 41693; ChemSpider: 38043; Bluelight: Sufentanil; Erowid: Sufentanil total synthesis; Wikipedia: Sufentanil
3D rendering of Tapentadol
Effective 28 Mar 2011, S.I. 2011/744 added:
On 13 Jan 2011, S.I. 2011/744* proposed to add:
Tapentadol
CA: CDSA Schedule I Section 22 Tapentadol
US: CSA Schedule II Section c Subsection 28 Tapentadol
⇒
PubChem: 9838022; ChemSpider: 8013742; Bluelight: Tapentadol; Drugs Forum: Tapentadol; Erowid: Tapentadol; Wikipedia: Tapentadol
3D rendering of Tenocyclidine
Effective 1 Jan 1985, S.I. 1984/859 added:
Tenocyclidine
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
US: CSA Schedule I Section d Subsection 34 Thiophene analog of Phencyclidine
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine
3D rendering of Thebacon
Thebacon
CA: CDSA Schedule I Section 1 Subsection 31 Thebacon
UN: Narcotics Part 1 Section 1 Thebacon
US: CSA Schedule I Section c Subsection 23 Thebacon
⇒
PubChem: 10075; ChemSpider: 9683173; Drugs Forum: Thebacon; Wikipedia: Thebacon
3D rendering of Thebaine
Thebaine
CA: CDSA Schedule I Section 1 Subsection 4 Thebaine
UN: Narcotics Part 1 Section 1 Thebaine
US: CSA Schedule II Section b Subsection 1 Item xvii Thebaine
⇒
PubChem: 5324289; ChemSpider: 4481822; Bluelight: Thebaine; Drugs Forum: Thebaine; Erowid: Poppy; Wikipedia: Thebaine
3D rendering of Tilidate
Effective 18 Jul 1983, S.I. 1983/765 added:
Tilidate
CA: CDSA Schedule I Section 17 Tilidine
UN: Narcotics Part 1 Section 1 Tilidine
US: CSA Schedule I Section b Subsection 54 Tilidine
⇒
PubChem: 32329 98526; ChemSpider: 29969; Bluelight: Tilidine; Drugs Forum: Tilidine; Wikipedia: Tilidine
3D rendering of Trimeperidine
Trimeperidine
CA: CDSA Schedule I Section 3 Subsection 21 Trimeperidine
UN: Narcotics Part 1 Section 1 Trimeperidine
US: CSA Schedule I Section b Subsection 55 Trimeperidine
⇒
PubChem: 98520 6148; ChemSpider: 88971; Wikipedia: Trimeperidine
3D rendering of (6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Effective 7 Jan 2015, S.I. 2014/3271 added:
On 30 Oct 2014, S.I. 2014/3271** proposed to add:
(6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52)
On 16 Jul 2014, S.I. 2014/3271* proposed to add:
(6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[5,4,3-fg]quinoline-9-carboxamide (ALD-52)
The systematic name given in the original, withdrawn amendment is fatally wrong. It does not describe the intended substance, nor any other known or possible structure.
3D rendering of Tryptamine
[Tryptamine (above) is explicitly not captured by this clause]
1(b)
Any compound (not being a compound for the time being specified in sub-paragraph (a) above structurally derived from Tryptamine or from a ring-hydroxy Tryptamine by modification in any of the following ways, that is to say—
  1. by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
  2. by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
  3. by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;
  4. by substitution at the 2-position of the tryptamine ring system with an alkyl substituent
Effective 7 Jan 2015, S.I. 2014/3271 replacement for:
On 30 Oct 2014, S.I. 2014/3271** proposed replacement for:
On 16 Jul 2014, S.I. 2014/3271* proposed replacement for:
Effective 20 Sep 1977, S.I. 1977/1243 added:
Any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from Tryptamine or from a ring-hydroxy Tryptamine by substitution at the nitrogen atom of a side-chain with one or more alkyl substituents but no other substituent.
This description of a “generic” controlled tryptamine includes mono- or di-N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) analogues.
Furthermore, paragraph 3 of this schedule extends its reach to ethers and esters of controlled substances, thereby embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
⇒
PubChem: 1150; ChemSpider: 1118; Wikipedia: Tryptamine
3D rendering of 5-Methoxy-N,N-diisopropyltryptamine
5-Methoxy-N,N-diisopropyltryptamine (Methyl ether of 5-Hydroxy-N,N-diisopropyltryptamine)
US: CSA Schedule I Section d Subsection 20 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
3D rendering of Psilocybin
Psilocybin (Phosphate ester of 4-Hydroxy-N,N-dimethyltryptamine)
CA: CDSA Schedule III Section 12 Psilocybin
UN: Psychotropics Schedule I Psilocybine
US: CSA Schedule I Section d Subsection 29 Psilocybin
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
3D rendering of 5-Methoxy-N,N-dimethyltryptamine
5-Methoxy-N,N-dimethyltryptamine (5-Methoxy-3-[2-(dimethylamino)ethyl)]indole; 5-MeO-DMT)
US: CSA Schedule I Section d Subsection 15 5-Methoxy-N,N-dimethyltryptamine
⇒
PubChem: 1832; ChemSpider: 1766; Bluelight: 5-MeO-DMT; Drugs Forum: 5-MeO-DMT; Erowid: 5-MeO-DMT; TiHKAL • info: 5-MeO-DMT; Wikipedia: 5-MeO-DMT
3D rendering of Phenethylamine
[Phenethylamine (above) is explicitly not captured by this clause]
Effective 1 Feb 2002, S.I. 2001/3932 added:
1(ba)
The following Phenethylamine derivatives, namely:
See also MDA Part I Class A Section 1(c) Phenethylamine
⇒
PubChem: 1001; ChemSpider: 13856352; Bluelight: Phenethylamine; Wikipedia: Phenethylamine
3D rendering of Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
ChemSpider: 21106331; PiHKAL • info: MDAL; Wikipedia: Methylenedioxyallylamphetamine
3D rendering of 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
⇒
ChemSpider: 21106263; PiHKAL • info: BOHD; Wikipedia: BOHD (psychedelic)
3D rendering of 2-Amino-1-(3,4-dimethoxyphenyl)ethanol
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
⇒
PubChem: 3863978; ChemSpider: 3088871; PiHKAL • info: DME; Wikipedia: DME (psychedelic)
3D rendering of Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
PubChem: 20507314; ChemSpider: 15110233; PiHKAL • info: MDBZ; Wikipedia: Methylenedioxybenzylamphetamine
3D rendering of 4-Bromo-β,2,5-trimethoxyphenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
4-Bromo-β,2,5-trimethoxyphenethylamine
⇒
PubChem: 15185771; ChemSpider: 21106261; PiHKAL • info: BOB; Wikipedia: BOB (psychedelic)
3D rendering of N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
⇒
PubChem: 44350007; ChemSpider: 21106319; PiHKAL • info: HOT-17; Wikipedia: HOT-17
3D rendering of Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
ChemSpider: 21106332; PiHKAL • info: MDCPM; Wikipedia: Methylenedioxycyclopropylmethylamphetamine
3D rendering of 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
⇒
PubChem: 44350123; ChemSpider: 23206516; PiHKAL • info: 2C-G-3; Wikipedia: 2C-G
3D rendering of 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
⇒
PubChem: 44350047; ChemSpider: 23206457; PiHKAL • info: G-3; Wikipedia: Ganesha (psychedelic)
3D rendering of 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
⇒
PubChem: 3017965; ChemSpider: 2285590; PiHKAL • info: DMCPA; Wikipedia: 4-Methyl-2,5-methoxyphenylcyclopropylamine
3D rendering of 2-(1,4-Dimethoxy-2-naphthyl)ethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
⇒
PubChem: 21796713; ChemSpider: 10546842; PiHKAL • info: 2C-G-N; Wikipedia: 2C-G
3D rendering of 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
⇒
PubChem: 9925746; ChemSpider: 8101381; PiHKAL • info: G-N; Wikipedia: Ganesha (psychedelic)
3D rendering of N-(2,5-Dimethoxy-4-propylthiophenthyl)hydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
N-(2,5-Dimethoxy-4-propylthiophenthyl)hydroxylamine
⇒
PubChem: 44350017; ChemSpider: 21106321; Bluelight: HOT-7; PiHKAL • info: HOT-7; Wikipedia: HOT-7
3D rendering of 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
⇒
PiHKAL • info: 2C-G-4; Wikipedia: 2C-G
3D rendering of 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
⇒
PiHKAL • info: G-4; Wikipedia: Ganesha (psychedelic)
3D rendering of α,α-Dimethyl-3,4-methylenedioxyphenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
α,α-Dimethyl-3,4-methylenedioxyphenethylamine
⇒
PubChem: 13020598; ChemSpider: 15204207; PiHKAL • info: MDPH; Wikipedia: Methylenedioxyphentermine
3D rendering of α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
⇒
PubChem: 44366836; ChemSpider: 21106335; PiHKAL • info: MDMP; Wikipedia: MDMP
3D rendering of Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
CA: CDSA Schedule I Section 19 Subsection 11 N,N-Dimethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 12 N,N-Dimethyl-3,4-methylenedioxyamphetamine
⇒
PubChem: 551630; ChemSpider: 479880; Bluelight: MDDMA; PiHKAL • info: MDDM; Wikipedia: MDDM
3D rendering of N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
⇒
PubChem: 44350142; ChemSpider: 21106320; PiHKAL • info: HOT-2; Wikipedia: HOT-2
3D rendering of 4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
⇒
PubChem: 135056; ChemSpider: 119009; PiHKAL • info: IDNNA; Wikipedia: IDNNA
3D rendering of 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
⇒
PubChem: 44349968; ChemSpider: 23206405; PiHKAL • info: 2C-G-5; Wikipedia: 2C-G
3D rendering of 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
⇒
PiHKAL • info: G5; Wikipedia: Ganesha (psychedelic)
3D rendering of 2-(5-Methoxy-2,2-dimethyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(5-Methoxy-2,2-dimethyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
⇒
PubChem: 16051705; ChemSpider: 13180083; PiHKAL • info: F-22; Wikipedia: F-22 (psychedelic)
3D rendering of 2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
⇒
ChemSpider: 21106334; PiHKAL • info: MDMEOET; Wikipedia: Methylenedioxymethoxyethylamphetamine
3D rendering of 2-(5-Methoxy-2-methyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(5-Methoxy-2-methyl-2,3-dihdrobenzo[b]furan-6-yl)-1-methylethylamine
⇒
PubChem: 13056773; ChemSpider: 21106309; PiHKAL • info: F2; Wikipedia: F-2 (psychedelic)
3D rendering of β-Methoxy-3,4-methylenedioxyphenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
β-Methoxy-3,4-methylenedioxyphenethylamine
⇒
PubChem: 44719487; ChemSpider: 21106264; PiHKAL • info: BOH; Wikipedia: BOH (drug)
3D rendering of 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
⇒
ChemSpider: 21106304; PiHKAL • info: ETHYL-K; Wikipedia: Ethylbenzodioxolylpentanamine
3D rendering of 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
⇒
PubChem: 17757316; ChemSpider: 21106348; PiHKAL • info: METHYL-K; Wikipedia: Methylbenzodioxolylpentanamine
3D rendering of 2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
Effective 1 Feb 2002, S.I. 2001/3932 added:
2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
⇒
PubChem: 21645837; ChemSpider: 15637662; PiHKAL • info: MDHOET; Wikipedia: Methylenedioxyhydroxyethylamphetamine
3D rendering of α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
Effective 1 Feb 2002, S.I. 2001/3932 added:
α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
⇒
ChemSpider: 21106336; PiHKAL • info: MDPL; Wikipedia: Methylenedioxypropargylamphetamine
3D rendering of N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
⇒
PubChem: 44350092; ChemSpider: 21106310; PiHKAL • info: FLEA; Wikipedia: Methylenedioxyhydroxymethamphetamine
3D rendering of O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
⇒
ChemSpider: 21106333; PiHKAL • info: MDMEO; Wikipedia: MDMEO
3D rendering of α-Methyl-4-(methylthio)phenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
α-Methyl-4-(methylthio)phenethylamine
UN: Psychotropics Schedule I 4-MTA
⇒
PubChem: 151900; ChemSpider: 133883; Erowid: 4-MTA; Wikipedia: 4-Methylthioamphetamine
3D rendering of β,3,4,5-Tetramethoxyphenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
β,3,4,5-Tetramethoxyphenethylamine
⇒
ChemSpider: 21106265; PiHKAL • info: BOM; Wikipedia: BOM (psychedelic)
3D rendering of β,2,5-Trimethoxy-4-methylphenethylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
β,2,5-Trimethoxy-4-methylphenethylamine
⇒
ChemSpider: 21106262; PiHKAL • info: BOD; Wikipedia: BOD (psychedelic)
3D rendering of Methoxyphenamine
[Methoxyphenamine (above) is explicitly not captured by this clause]
Phenethylamine skeleton
[Phenethylamine (above) is explicitly not captured by this clause]
Effective 20 Sep 1977, S.I. 1977/1243 added:
1(c)
Any compound (not being Methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from Phenethylamine, an N-alkylphenethylamine, ɑ-methylphenethylamine, an N-alkyl-ɑ-methylphenethylamine, ɑ-ethylphenethylamine, or an N-alkyl-ɑ-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, aklylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
⇒
PubChem: 4117; ChemSpider: 3974; Wikipedia: Methoxyphenamine
See also MDA Part I Class A Section 1(ba) Phenethylamine
⇒
PubChem: 1001; ChemSpider: 13856352; Bluelight: Phenethylamine; Wikipedia: Phenethylamine
3D rendering of 4-Bromo-2,5-dimethoxyphenethylamine
4-Bromo-2,5-dimethoxyphenethylamine
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UN: Psychotropics Schedule II 2 C-B
US: CSA Schedule I Section d Subsection 3 4-Bromo-2,5-dimethoxyphenethylamine
⇒
PubChem: 98527; ChemSpider: 88978; Bluelight: 2C-B; Drugs Forum: 2C-B; Erowid: 2C-B; PiHKAL • info: 2C-B; Wikipedia: 2C-B
3D rendering of 4-Chloro-2,5-dimethoxyphenethylamine
4-Chloro-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 40 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
⇒
PubChem: 29979100; ChemSpider: 21106221; Bluelight: 2C-C; Drugs Forum: 2C-C; Erowid: 2C-C; Wikipedia: 2C-C
3D rendering of 2,5-Dimethoxy-4-methylphenethylamine
2,5-Dimethoxy-4-methylphenethylamine
US: CSA Schedule I Section d Subsection 39 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
⇒
PubChem: 135740; ChemSpider: 119559; Bluelight: 2C-D; Drugs Forum: 2C-D; Erowid: 2C-D; Wikipedia: 2C-D
3D rendering of 4-Ethyl-2,5-dimethoxyphenethylamine
4-Ethyl-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 38 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
⇒
PubChem: 24729233; ChemSpider: 21106222; Bluelight: 2C-E; Drugs Forum: 2C-E; Erowid: 2C-E; Wikipedia: 2C-E
3D rendering of 2,5-Dimethoxyphenethylamine
2,5-Dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 44 2-(2,5-Dimethoxyphenyl)ethanamine
⇒
PubChem: 76632; ChemSpider: 69096; Wikipedia: 2C-H
3D rendering of 4-Iodo-2,5-dimethoxyphenethylamine
4-Iodo-2,5-dimethoxyphenethylamine
EU: Substances Substances 2C-I
US: CSA Schedule I Section d Subsection 41 2-(4-Iodo-2,5-dimethoxy-phenyl)ethanamine
⇒
PubChem: 10267191; ChemSpider: 8442670; Bluelight: 2C-I; Drugs Forum: 2C-I; Erowid: 2C-I; Wikipedia: 2C-I
3D rendering of 4-Isopropylthio-2,5-dimethoxyphenethylamine
4-Isopropylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 43 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
See also MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine
⇒
PubChem: 44350070; ChemSpider: 21106232; Bluelight: 2C-T-4; Erowid: 2C-T-4; Wikipedia: 2C-T-4
3D rendering of 2,5-Dimethoxy-4-propylphenethylamine
2,5-Dimethoxy-4-propylphenethylamine
US: CSA Schedule I Section d Subsection 46 2-(2,5-Dimethoxy-4-(n)-propyl-phenyl)ethanamine
⇒
PubChem: 44350080; ChemSpider: 21106226; Bluelight: 2C-P; Drugs Forum: 2C-P; Erowid: 2C-P; Wikipedia: 2C-P
3D rendering of 4-Ethylthio-2,5-dimethoxyphenethylamine
4-Ethylthio-2,5-dimethoxyphenethylamine
EU: Substances Substances 2C-T-2
US: CSA Schedule I Section d Subsection 42 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
⇒
PubChem: 12074193; ChemSpider: 16787961; Bluelight: 2C-T-2; Drugs Forum: 2C-T-2; Erowid: 2C-T-2; Wikipedia: 2C-T-2
3D rendering of 4-Isopropylthio-2,5-dimethoxyphenethylamine
4-Isopropylthio-2,5-dimethoxyphenethylamine
US: CSA Schedule I Section d Subsection 43 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine
See also MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine
⇒
PubChem: 44350070; ChemSpider: 21106232; Bluelight: 2C-T-4; Erowid: 2C-T-4; Wikipedia: 2C-T-4
3D rendering of 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
EU: Substances Substances 2C-T-7
US: CSA Schedule I Section d Subsection 6 2,5-Dimethoxy-4-(n)-propylthiophenenthylamine
⇒
PubChem: 24728635; ChemSpider: 21106233; Bluelight: 2C-T-7; Drugs Forum: 2C-T-7; Erowid: 2C-T-7; PiHKAL • info: 2C-T-7; Wikipedia: 2C-T-7
3D rendering of 4-Chloro-2,5-dimethoxyamphetamine
4-Chloro-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 15 4-Chloro-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 16 4-Chloro-2,5-dimethoxyamphetamine
⇒
PubChem: 542036; ChemSpider: 472008; Bluelight: DOC; Drugs Forum: DOC; Erowid: DOC; PiHKAL • info: DOC; Wikipedia: 2,5-Dimethoxy-4-chloroamphetamine
3D rendering of 2,5-Dimethoxyamphetamine
2,5-Dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
US: CSA Schedule I Section d Subsection 4 2,5-Dimethoxyamphetamine
⇒
PubChem: 62787; ChemSpider: 56526; PiHKAL • info: 2,5-DMA; Wikipedia: Dimethoxyamphetamine
3D rendering of 4-Ethoxyamphetamine
4-Ethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 16 4-Ethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 17 4-Ethoxyamphetamine
⇒
PubChem: 125379; ChemSpider: 111573; Wikipedia: Para-Ethoxyamphetamine
3D rendering of 4-Ethoxy-2,5-dimethoxyamphetamine
4-Ethoxy-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 9 4-Ethoxy-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 10 4-Ethoxy-2,5-dimethoxyamphetamine
⇒
PubChem: 542053; ChemSpider: 472023; PiHKAL • info: MEM; Wikipedia: MEM (psychedelic)
3D rendering of 4-Ethyl-2,5-dimethoxyamphetamine
4-Ethyl-2,5-dimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
US: CSA Schedule I Section d Subsection 5 2,5-Dimethoxy-4-ethylamphetamine
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
3D rendering of N-Ethyl-3,4-methylenedioxyamphetamine
N-Ethyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
US: CSA Schedule I Section d Subsection 12 3,4-Methylenedioxy-N-ethylamphetamine
⇒
PubChem: 105039; ChemSpider: 94775; Bluelight: MDE; Drugs Forum: MDEA; Erowid: MDE; PiHKAL • info: MDE; Wikipedia: Methylenedioxyethylamphetamine
3D rendering of 4-Methoxyamphetamine
4-Methoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
US: CSA Schedule I Section d Subsection 7 4-Methoxyamphetamine
⇒
PubChem: 31721; ChemSpider: 29417; Bluelight: PMA; Drugs Forum: PMA; Erowid: PMA; PiHKAL • info: 4-MA; Wikipedia: para-Methoxyamphetamine
3D rendering of 5-Methoxy-3,4-methylenedioxyamphetamine
5-Methoxy-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
US: CSA Schedule I Section d Subsection 8 5-Methoxy-3,4-methylenedioxyamphetamine
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
3D rendering of 3,4-Methylenedioxyamphetamine
3,4-Methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UN: Psychotropics Schedule I Tenamfetamine (MDA)
US: CSA Schedule I Section d Subsection 10 3,4-Methylenedioxyamphetamine
⇒
PubChem: 1614; ChemSpider: 1555; Bluelight: MDA; Drugs Forum: MDA; Erowid: MDA; PiHKAL • info: MDA; Wikipedia: 3,4-Methylenedioxyamphetamine
3D rendering of N-Methyl-3,4-methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
US: CSA Schedule I Section d Subsection 11 3,4-Methylenedioxymethamphetamine
⇒
PubChem: 1615; ChemSpider: 1556; Bluelight: MDMA; Drugs Forum: MDMA; Erowid: MDMA; PiHKAL • info: MDMA; Wikipedia: Methylenedioxymethamphetamine
3D rendering of N-Propyl-3,4-methylenedioxyamphetamine
N-Propyl-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 18 N-Propyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 19 N-Propyl-3,4-methylenedioxyamphetamine
⇒
PubChem: 559375; ChemSpider: 486273; Erowid: MDPR; PiHKAL • info: MDPR; Wikipedia: MDPR
3D rendering of 2,4,5-Trimethoxyamphetamine
2,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 7 2,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 8 2,4,5-Trimethoxyamphetamine
EU: Substances Substances TMA-2
⇒
PubChem: 31014; ChemSpider: 28773; Drugs Forum: TMA-2; Erowid: TMA-2; PiHKAL • info: TMA-2; Wikipedia: Trimethoxyamphetamine
3D rendering of 3,4,5-Trimethoxyamphetamine
3,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
US: CSA Schedule I Section d Subsection 14 3,4,5-Trimethoxyamphetamine
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Fentanyl
Fentanyl
Effective 1 Apr 1987, S.I. 1986/2230 added:
1(d)
Any compound (not being a compound for the time being specified in sub-paragraph (a) above structurally derived from Fentanyl by modification in any of the following ways, that is to say:
  1. by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
  2. by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
  3. by substitution in the piperidine ring with alkyl or alkenyl groups;
  4. by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;
  5. by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
  6. by replacement of the N-propionyl group by another acyl group.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
CA: CDSA Schedule I Section 16 Fentanyls
See also MDA Part I Class A Section 1(a) Fentanyl
3D rendering of Acetyl-α-methylfentanyl
Acetyl-α-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 1 Acetyl-α-methylfentanyl
UN: Narcotics Part 1 Section 1 Acetyl-alpha-methylfentanyl and Section 3 Acetyl-alpha-methylfentanyl
US: CSA Schedule I Section b Subsection 1 Acetyl-alpha-methylfentanyl
⇒
PubChem: 62307; ChemSpider: 56102
3D rendering of p-Fluorofentanyl
p-Fluorofentanyl
CA: CDSA Schedule I Section 16 Subsection 4 p-Fluorofentanyl
UN: Narcotics Part 1 Section 1 Para-Fluorofentanyl and Section 3 Para-Fluorofentanyl
US: CSA Schedule I Section b Subsection 42 Para-fluorofentanyl
⇒
PubChem: 62300; ChemSpider: 56096; Wikipedia: Parafluorofentanyl
3D rendering of β-Hydroxyfentanyl
β-Hydroxyfentanyl
CA: CDSA Schedule I Section 16 Subsection 6 β-Hydroxyfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxyfentanyl and Section 3 Beta-Hydroxyfentanyl
US: CSA Schedule I Section b Subsection 11 Beta-hydroxyfentanyl
⇒
PubChem: 62278; ChemSpider: 56079; Wikipedia: Betahydroxyfentanyl
3D rendering of β-Hydroxy-3-methylfentanyl
β-Hydroxy-3-methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 7 β-Hydroxy-3-methylfentanyl
UN: Narcotics Part 1 Section 1 Beta-Hydroxy-3-methylfentanyl and Section 3 Beta-Hydroxy-3-methylfentanyl
US: CSA Schedule I Section b Subsection 12 Beta-hydroxy-3-methylfentanyl
⇒
PubChem: 62279; ChemSpider: 56080; Wikipedia: Ohmefentanyl
3D rendering of α-Methylfentanyl
α-Methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 8 α-Methylfentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylfentanyl and Section 3 Alpha-Methylfentanyl
US: CSA Schedule I Section b Subsection 7 Alpha-methylfentanyl
⇒
PubChem: 62281; ChemSpider: 56081; Wikipedia: Alphamethylfentanyl
3D rendering of α-Methylthiofentanyl
α-Methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 9 α-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 Alpha-Methylthiofentanyl and Section 3 Alpha-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 8 Alpha-methylthiofentanyl
⇒
PubChem: 62309; ChemSpider: 56104; Wikipedia: Alphamethylthiofentanyl
3D rendering of 3-Methylfentanyl
3-Methylfentanyl
CA: CDSA Schedule I Section 16 Subsection 10 3-Methylfentanyl
UN: Narcotics Part 1 Section 1 3-Methylfentanyl and Section 3 3-Methylfentanyl
US: CSA Schedule I Section b Subsection 34 3-Methylfentanyl
⇒
PubChem: 61996; ChemSpider: 55844; Wikipedia: 3-Methylfentanyl
3D rendering of 3-Methylthiofentanyl
3-Methylthiofentanyl
CA: CDSA Schedule I Section 16 Subsection 11 3-Methylthiofentanyl
UN: Narcotics Part 1 Section 1 3-Methylthiofentanyl and Section 3 3-Methylthiofentanyl
US: CSA Schedule I Section b Subsection 35 3-Methylthiofentanyl
⇒
PubChem: 62296; ChemSpider: 56092; Wikipedia: 3-Methylthiofentanyl
3D rendering of Thiofentanyl
Thiofentanyl
CA: CDSA Schedule I Section 16 Subsection 13 Thiofentanyl
UN: Narcotics Part 1 Section 1 Thiofentanyl and Section 3 Thiofentanyl
US: CSA Schedule I Section b Subsection 53 Thiofentanyl
⇒
PubChem: 62380; ChemSpider: 56168; Wikipedia: Thiofentanyl
Pethidine skeleton
Pethidine
Effective 1 Apr 1987, S.I. 1986/2230 added:
1(e)
Any compound (not being a compound for the time being specified in sub-paragraph (a) above structurally derived from Pethidine by modification in any of the following ways, that is to say:
  1. by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
  2. by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
  3. by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
  4. by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or alkoxyalkyl or acyloxy group;
  5. by formation of an N-oxide or of a quaternary base.
CA: CDSA Schedule I Section 3 Phenylpiperidines
CA: CDSA Schedule I Section 3 Subsection 17 Pethidine
UN: Narcotics Part 1 Section 1 Pethidine
US: CSA Schedule II Section c Subsection 18 Pethidine
See also MDA Part I Class A Section 1(a) Pethidine
⇒
PubChem: 4058; ChemSpider: 3918; Erowid: Meperidine; Wikipedia: Pethidine
N-Benzylphenethylamine skeleton
N-Benzylphenethylamine skeleton
3D rendering of Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
[Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine (above) is explicitly not captured by this clause]
3D rendering of Mescaline
Mescaline
3D rendering of 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
4-Bromo-2,5-dimethoxy-α-methylphenethylamine
3D rendering of 2,5-Dimethoxy-α,4-dimethylphenethylamine
2,5-Dimethoxy-α,4-dimethylphenethylamine
3D rendering of N-Hydroxytenamphetamine
N-Hydroxytenamphetamine
Effective 10 Jun 2014, S.I. 2014/1106 added:
On 5 Mar 2014, S.I. 2014/1106* proposed to add:
1(f)
any compound (not being Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from Mescaline, 4-Bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-Dimethoxy-α,4-dimethylphenethylamine, N-Hydroxytenamphetamine, or a compound specified in sub-paragraph (ba) or sub-paragraph (c) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.
The substances below, formerly controlled as temporary class drugs, are captured by this generic definition along with are infinitely many others which… this page is too narrow to contain.
CA: CDSA Schedule III Section 17 Mescaline
UN: Psychotropics Schedule I Mescaline
US: CSA Schedule I Section d Subsection 24 Mescaline
See also MDA Part I Class A Section 1(a) Mescaline
⇒
PubChem: 4076; ChemSpider: 3934; Drugs Forum: Mescaline; Erowid: Mescaline; PiHKAL • info: M; Wikipedia: Mescaline
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
US: CSA Schedule I Section d Subsection 2 4-Bromo-2,5-dimethoxyamphetamine
See also MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
⇒
PubChem: 62065; ChemSpider: 55902; Bluelight: DOB; Drugs Forum: DOB; Erowid: DOB; PiHKAL • info: DOB; Wikipedia: 2,5-Dimethoxy-4-bromoamphetamine
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I STP (DOM)
US: CSA Schedule I Section d Subsection 9 4-Methyl-2,5-dimethoxyamphetamine
See also MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine
⇒
PubChem: 85875; ChemSpider: 77462; Bluelight: DOM; Drugs Forum: DOM; Erowid: STP; PiHKAL • info: DOM; Wikipedia: 2,5-Dimethoxy-4-methylamphetamine
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
US: CSA Schedule I Section d Subsection 13 N-Hydroxy-3,4-methylenedioxyamphetamine
See also MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine
⇒
PubChem: 98528; ChemSpider: 88979; PiHKAL • info: MDOH; Wikipedia: MDOH
3D rendering of 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
US: CSA Schedule I Section h Subsection 4 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Previously at MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 10251906; ChemSpider: 8427392; Bluelight: 25I-NBOMe; Drugs Forum: 25I-NBOMe; Erowid: 25I-NBOMe; Wikipedia: 25I-NBOMe
3D rendering of 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: CSA Schedule I Section h Subsection 6 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Previously at MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 9977044; ChemSpider: 8152636; Bluelight: 25B-NBOMe; Drugs Forum: 25B-NBOMe; Wikipedia: 25B-NBOMe
3D rendering of 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: Previously at MDA Temporary Class Drug Orders 2013 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
ChemSpider: 29341727; Drugs Forum: 25D-NBOMe; Wikipedia: 25D-NBOMe
3D rendering of 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
US: CSA Schedule I Section h Subsection 5 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
UK: Previously at MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
⇒
PubChem: 46856354; ChemSpider: 24583389; Bluelight: 25C-NBOMe; Drugs Forum: 25C-NBOMe; Erowid: 25C-NBOMe; Wikipedia: 25C-NBOMe
3D rendering of Dextromethorphan
[Dextromethorphan (above) is explicitly not captured by this clause]
3D rendering of Dextrorphan
[Dextrorphan (above) is explicitly not captured by this clause]
2
Any stereoisomeric form of a substance for the time being specified in paragraph 1 not being dextromethorphan or dextrorphan.
CA: [not controlled] CDSA Schedule I Section 10 Subsection 10 Dextromethorphan
⇒
PubChem: 5360696; ChemSpider: 13109865; Bluelight: DXM; Drugs Forum: DXM; Wikipedia: Dextromethorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 11 Dextrorphan
⇒
PubChem: 5360697; ChemSpider: 10489895; Wikipedia: Dextrorphan
3
Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II of this Schedule.
Effective 1 Jul 1973, S.I. 1973/771 replacement for:
Any ester or ether of a substances for the time being specified in paragraph 1 or 2 above.
4
Any salt of a substance for the time being specified in any of paragraphs 1 to 3.
5
Any preparation of other product containing a substance or product for the time being specified in any of paragraphs 1 to 4.
6
Any preparation designated for administration by injection specified in any of paragraphs 1 to 3 of Part II of this Schedule.
Part II Class B Drugs
Source: L. A. King, Forensic Chemistry of Substance Misuse: A Guide to Drug Control, RSC Publishing, Cambridge, 2009
1(a)
The following substances and products, namely:
3D rendering of Acetyldihydrocodeine
Acetyldihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 6 Acetyldihydrocodeine
UN: Narcotics Part 1 Section 2 Acetyldihydrocodeine and Part 2 Section 1 Acetyldihydrocodeine
US: CSA Schedule I Section c Subsection 2 Acetyldihydrocodeine
⇒
PubChem: 5463874; ChemSpider: 4576412; Wikipedia: Acetyldihydrocodeine
3D rendering of Amphetamine
Amphetamine
CA: CDSA Schedule I Section 19 Subsection 1 Amphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 1 Amphetamine
UN: Psychotropics Schedule II Amfetamine (Amphetamine)
US: CSA Schedule II Section d Subsection 1 Amphetamine
UK: Previously at MDA Part II Class B Section 1(a)
⇒
PubChem: 3007; ChemSpider: 13852819; Bluelight: Amphetamine; Drugs Forum: Amphetamine; Erowid: Amphetamine; Wikipedia: Amphetamine
3D rendering of Cannabinol
Effective 26 Jan 2009, S.I. 2008/3130 added:
Cannabinol
CA: CDSA Schedule II Section 1 Subsection 4 Cannabinol
UK: Previously at MDA Part III Class C Section 1(a)
See also MDA Part II Class B Section 1(a) Cannabinol
⇒
PubChem: 2543; ChemSpider: 2447; Drugs Forum: Cannabinol; Erowid: Cannabis; Wikipedia: Cannabinol
Cannabinol nucleus
Cannabinol
Tetrahydroannabinol nucleus
Tetrahydrocannabinol
where R = pentyl = C5H11
Effective 26 Jan 2009, S.I. 2008/3130 added:
Cannabinol derivatives [Cannabinol derivatives means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives.]
UK: Previously at MDA Part III Class C Section 1(a)
CA: CDSA Schedule II Section 1 Subsection 4 Cannabinol
UK: Previously at MDA Part III Class C Section 1(a)
See also MDA Part II Class B Section 1(a) Cannabinol
⇒
PubChem: 2543; ChemSpider: 2447; Drugs Forum: Cannabinol; Erowid: Cannabis; Wikipedia: Cannabinol
CA: CDSA Schedule II Section 1 Subsection 7 Tetrahydrocannabinol
US: CSA Schedule I Section d Subsection 31 Δ1 cis or trans Tetrahydrocannabinol
UK: Previously at MDA Part III Class C Section 1(a)
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: Tetrahydrocannabinol

Effective 26 Jan 2009, S.I. 2008/3130 added:
Effective 29 Jan 2004, S.I. 2003/3201 revoked:
Cannabis and Cannabis resin
CA: CDSA Schedule II Section 1 Subsection 2 Cannabis, Schedule VII Section 2 Cannabis and Schedule VIII Section 2 Cannabis
UN: Narcotics Part 1 Section 1 Cannabis and Section 3 Cannabis
US: CSA Schedule I Section d Subsection 23 Marihuana
UK: Previously at MDA Part III Class C Section 1(a)
⇒
PubChem: 423122; Bluelight: Cannabis; Drugs Forum: Cannabis; Erowid: Cannabis; Wikipedia: Cannabis
CA: CDSA Schedule II Section 1 Subsection 1 Cannabis resin, Schedule VII Section 1 Cannabis resin and Schedule VIII Section 1 Cannabis resin
UN: Narcotics Part 1 Section 1 Cannabis resin and Section 3 Cannabis resin
⇒
PubChem: 9648; Drugs Forum: Cannabis resin; Wikipedia: Cannabis (drug)
3D rendering of Codeine
Codeine
CA: CDSA Schedule I Section 1 Subsection 2 Codeine
UN: Narcotics Part 1 Section 2 Codeine and Part 2 Section 1 Codeine
US: CSA Schedule II Section b Subsection 1 Item i Codeine, Schedule III Section e Subsection 1 Item i Codeine, Item ii Codeine and Schedule V Section c Subsection 1 Codeine
⇒
PubChem: 5284371; ChemSpider: 4447447; Drugs Forum: Codeine; Erowid: Codeine; Wikipedia: Codeine
Effective 1 Apr 1986, S.I. 1985/1995 revoked:
Dexamphetamine
UK: Currently at MDA Part II Class B Section 1(a) Amphetamine
3D rendering of Dihydrocodeine
Dihydrocodeine
CA: CDSA Schedule I Section 1 Subsection 11 Dihydrocodeine
UN: Narcotics Part 1 Section 2 Dihydrocodeine and Part 2 Section 1 Dihydrocodeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
⇒
PubChem: 5284543; ChemSpider: 4447600; Erowid: Dihydrocodeine; Wikipedia: Dihydrocodeine
3D rendering of Ethylmorphine
Ethylmorphine (3-Ethylmorphine)
CA: CDSA Schedule I Section 1 Subsection 13 Ethylmorphine
UN: Narcotics Part 1 Section 2 Ethylmorphine and Part 2 Section 1 Ethylmorphine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
⇒
PubChem: 5359271; ChemSpider: 4514250; Wikipedia: Ethylmorphine
3D rendering of Glutethimide
Effective 1 Apr 1986, S.I. 1985/1995 added:
Glutethimide
CA: CDSA Schedule IV Section 11 Glutethimide
UN: Psychotropics Schedule III Glutethimide
US: CSA Schedule II Section e Subsection 2 Glutethimide
⇒
PubChem: 3487; ChemSpider: 3367; Wikipedia: Glutethimide
3D rendering of Ketamine
Effective 10 Jun 2014, S.I. 2014/1106 added:
On 5 Mar 2014, S.I. 2014/1106* proposed to add:
Ketamine
CA: CDSA Schedule I Section 14 Subsection 1 Ketamine
US: CSA Schedule III Section c Subsection 7 Ketamine
See also MDA Part III Class C Section 1(a) Ketamine
⇒
PubChem: 3821; ChemSpider: 3689; Bluelight: Ketamine; Bluelight: Ketamine; Drugs Forum: Ketamine; Erowid: Ketamine; Wikipedia: Ketamine
3D rendering of Lefetamine
Effective 1 Apr 1986, S.I. 1985/1995 added:
Lefetamine
CA: CDSA Schedule III Section 29 Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
3D rendering of Lisdexamfetamine
Effective 10 Jun 2014, S.I. 2014/1106 added:
On 5 Mar 2014, S.I. 2014/1106* proposed to add:
Lisdexamfetamine
US: CSA Schedule II Section d Subsection 5 Lisdexamfetamine
⇒
PubChem: 11597698; ChemSpider: 9772458; Wikipedia: Lisdexamfetamine
3D rendering of Mecloqualone
Effective 1 Jan 1985, S.I. 1984/859 added:
Mecloqualone
CA: CDSA Schedule III Section 4 Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
US: CSA Schedule I Section e Subsection 2 Mecloqualone
⇒
PubChem: 9567; ChemSpider: 9192; Wikipedia: Mecloqualone
3D rendering of Methaqualone
Effective 1 Jan 1985, S.I. 1984/859 added:
Methaqualone
CA: CDSA Schedule III Section 3 Methaqualone
UN: Psychotropics Schedule II Methaqualone
US: CSA Schedule I Section e Subsection 3 Methaqualone
UK: Previously at MDA Part III Class C Section 1(a)
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: Methaqualone
3D rendering of Methcathinone
Effective 1 May 1998, S.I. 1998/750 added:
Methcathinone
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UN: Psychotropics Schedule I Methcathinone
US: CSA Schedule I Section f Subsection 5 Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Effective 18 Jan 2007, S.I. 2006/3331 revoked:
Methylamphetamine
UK: Currently at MDA Part I Class A Section 1(a) Methylamphetamine
Effective 28 Mar 2011, S.I. 2011/744 revoked:
On 13 Jan 2011, S.I. 2011/744* proposed to revoke:
Effective 16 Apr 2010, S.I. 2010/1207 added:
4-Methylmethcathinone
UK: Currently at MDA Part II Class B Section 1(aa) 2-Amino-1-phenyl-1-propanone
3D rendering of α-Methylphenethylhydroxylamine
Effective 1 Feb 2002, S.I. 2001/3932 added:
α-Methylphenethylhydroxylamine
⇒
PubChem: 65546; ChemSpider: 58990
3D rendering of Methylphenidate
Methylphenidate
CA: CDSA Schedule III Section 2 Methylphenidate
UN: Psychotropics Schedule II Methylphenidate
US: CSA Schedule II Section d Subsection 4 Methylphenidate
⇒
PubChem: 4158; ChemSpider: 4015; Bluelight: Methylphenidate; Drugs Forum: Methylphenidate; Erowid: Methylphenidate; Wikipedia: Methylphenidate
3D rendering of Methylphenobarbitone
Effective 1 Jan 1985, S.I. 1984/859 added:
Methylphenobarbitone
CA: CDSA Schedule IV Section 1 Subsection 18 Methylphenobarbital
UN: Psychotropics Schedule IV Methylphenobarbital
⇒
PubChem: 8271; ChemSpider: 7972; Wikipedia: Methylphenobarbital
3D rendering of Nicocodine
Nicocodine
CA: CDSA Schedule I Section 1 Subsection 24 Nicocodine
UN: Narcotics Part 1 Section 2 Nicocodine and Part 2 Section 1 Nicocodine
US: CSA Schedule I Section c Subsection 19 Nicocodeine
⇒
PubChem: 5463872; ChemSpider: 4576411; Wikipedia: Nicocodeine
3D rendering of Nicodicodine
Effective 1 Jul 1973, S.I. 1973/771 added:
Nicodicodine (6-Nicotinoyldihydrocodeine)
UN: Narcotics Part 1 Section 2 Nicodicodine and Part 2 Section 1 Nicodicodine
UK: Previously at MDA Part I Class A Section 1(a)
⇒
PubChem: 5464304; ChemSpider: 4576612; Wikipedia: Nicodicodeine
3D rendering of Norcodeine
Norcodeine
CA: CDSA Schedule I Section 1 Subsection 26 Norcodeine
UN: Narcotics Part 1 Section 2 Norcodeine and Part 2 Section 1 Norcodeine
⇒
PubChem: 398686 20056621 16759999 9925873; ChemSpider: 8101508; Wikipedia: Norcodeine
3D rendering of Metazocine
Effective 1 Apr 1986, S.I. 1985/1995 added:
Metazocine
CA: CDSA Schedule I Section 11 Subsection 2 Metazocine
UN: Narcotics Part 1 Section 1 Metazocine and Psychotropics Schedule III Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
See also MDA Part I Class A Section 1(a) Metazocine
⇒
PubChem: 3037886; ChemSpider: 391630; Wikipedia: Metazocine
3D rendering of Phenmetrazine
Phenmetrazine
CA: CDSA Schedule IV Section 6 Phenmetrazine
UN: Psychotropics Schedule II Phenmetrazine
US: CSA Schedule II Section d Subsection 3 Phenmetrazine
⇒
PubChem: 4762; ChemSpider: 4598; Drugs Forum: Phenmetrazine; Wikipedia: Phenmetrazine
3D rendering of Pholcodine
Pholcodine
CA: CDSA Schedule I Section 1 Subsection 30 Pholcodine
UN: Narcotics Part 1 Section 2 Pholcodine and Part 2 Section 1 Pholcodine
US: CSA Schedule I Section c Subsection 22 Pholcodine
⇒
PubChem: 5311356; ChemSpider: 4470854; Bluelight: Pholcodine; Drugs Forum: Pholcodine; Wikipedia: Pholcodine
3D rendering of Propiram
Effective 1 Jul 1973, S.I. 1973/771 added:
Propiram
CA: CDSA Schedule I Section 12 Subsection 3 Propiram
UN: Narcotics Part 1 Section 2 Propiram and Part 2 Section 2 Propiram
US: CSA Schedule I Section b Subsection 51 Propiram
⇒
PubChem: 26216; ChemSpider: 24426; Wikipedia: Propiram
3D rendering of Zipeprol
Effective 1 May 1998, S.I. 1998/750 added:
Zipeprol
CA: CDSA Schedule III Section 31 Zipeprol
UN: Psychotropics Schedule II Zipeprol
⇒
PubChem: 36910; ChemSpider: 33868; Wikipedia: Zipeprol
3D rendering of 2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol
Effective 26 Feb 2013, S.I. 2013/239 added:
On 8 Jan 2013, S.I. 2013/239* proposed to add:
2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol
⇒
PubChem: 130829; ChemSpider: 115703; Wikipedia: O-Desmethyltramadol
Amino-1-phenyl-1-propanone nucleus
2-Amino-1-phenyl-1-propanone
3D rendering of Cathinone
Cathinone
3D rendering of Diethylpropion
Diethylpropion
3D rendering of Pyrovalerone
Pyrovalerone
3D rendering of Bupropion
[Bupropion (above) is explicitly not captured by this clause]
3D rendering of 4-Methylmethcathinone; Mephedrone
4-Methylmethcathinone; Mephedrone, one of many new cathinone analogues this amendment adds to Class B.
3D rendering of Flephedrone
Flephedrone, one of many new cathinone analogues this amendment adds to Class B.
3D rendering of Methylone
Methylone, one of many new cathinone analogues this amendment adds to Class B.
3D rendering of Butylone
Butylone, one of many new cathinone analogues this amendment adds to Class B.
3D rendering of MDPV
MDPV, one of many new cathinone analogues this amendment adds to Class B.
Effective 16 Apr 2010, S.I. 2010/1207 added:
1(aa)
Any compound (not being Bupropion, Cathinone, Diethylpropion, Pyrovalerone or a compound for the time being specified in sub-paragraph (a) above) structurally derived from 2-Amino-1-phenyl-1-propanone by modification in any of the following ways, that is to say,
  1. by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
  2. by substitution at the 3-position with an alkyl substituent;
  3. by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
Only a handful of the Cathinone analogues captured by this amendment are shown below. For a more comprehensive enumeration, I highly recommend Synchronium’s elegant depiction, an inspiring model of information design.
⇒
PubChem: 444
⇒
PubChem: 444; ChemSpider: 431; Drugs Forum: Bupropion; Wikipedia: Bupropion
CA: CDSA Schedule III Section 19 Cathinone
UN: Psychotropics Schedule I Cathinone
US: CSA Schedule I Section f Subsection 3 Cathinone
See also MDA Part III Class C Section 1(a) Cathinone
⇒
PubChem: 107786; ChemSpider: 96940; Erowid: Cathinone; Wikipedia: Cathinone
CA: CDSA Schedule IV Section 4 Diethylpropion
UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
US: CSA Schedule IV Section f Subsection 2 Diethylpropion
See also MDA Part III Class C Section 1(a) Diethylpropion
⇒
PubChem: 7029; ChemSpider: 6762; Wikipedia: Amfepramone
CA: CDSA Schedule IV Section 26 Pyrovalerone
UN: Psychotropics Schedule IV Pyrovalerone
US: CSA Schedule V Section d Subsection 1 Pyrovalerone
See also MDA Part III Class C Section 1(a) Pyrovalerone
⇒
PubChem: 14373; ChemSpider: 13733; Wikipedia: Pyrovalerone
EU: Substances Substances 4-Methylmethcathinone
US: CSA Schedule I Section d Subsection 36 4-Methylmethcathinone
UK: Previously at MDA Part II Class B Section 1(a)
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
US: CSA Schedule I Section h Subsection 17 4-Fluoro-N-methylcathinone
⇒
PubChem: 49853406; ChemSpider: 21477355; Drugs Forum: Flephedrone; Erowid: 4-Fluoromethcathinone (4-FMC); Wikipedia: 4-Fluoromethcathinone
US: CSA Schedule I Section d Subsection 47 3,4-Methylenedioxy-N-methylcathinone
⇒
PubChem: 45789647; ChemSpider: 21106350; Bluelight: Methylone; Drugs Forum: Methylone; Erowid: Methylone; Wikipedia: Methylone
US: CSA Schedule I Section h Subsection 14 Butylone
⇒
PubChem: 56843046; ChemSpider: 21106270; Bluelight: Butylone; Drugs Forum: Butylone; Erowid: bk-MBDB; Wikipedia: Bk-MBDB
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
US: CSA Schedule I Section d Subsection 37 3,4-Methylenedioxypyrovalerone
⇒
PubChem: 20111961; ChemSpider: 16788110; Bluelight: MDPV; Drugs Forum: MDPV; Erowid: MDPV; Wikipedia: Methylenedioxypyrovalerone
Aminopropan-1-one nucleus
2-Aminopropan-1-one
3D rendering of Naphthylpyrovalerone
Naphthylpyrovalerone (Naphyrone), one of many new cathinone analogues this amendment adds to Class B.
Effective 21 Jul 2010, S.I. 2010/1833 added:
1(ab)
Any compound structurally derived from 2-Aminopropan-1-one by substitution at the 1-position with any monocyclic, or fused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,
  1. by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
  2. by substitution at the 3-position with an alkyl substituent;
  3. by substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
⇒
PubChem: 53415330; ChemSpider: 24958236; Wikipedia: 3-Fluoromethcathinone
US: CSA Schedule I Section h Subsection 19 Naphyrone
⇒
PubChem: 11243002; ChemSpider: 9418039; Drugs Forum: Naphthylpyrovalerone; Wikipedia: Naphyrone
Pipradrol analogues
[Generic Diphenylmethyl heterocycle.
R1 = H, alkyl, alkoxy, haloalkyl or halide;
R2 = H, alkyl, hydroxyalkyl or hydroxy;
RN = piperidine, pyrrolidine, azepane, morpholine or pyridine.

The heterocycle nitrogen may have an alkyl, alkenyl, haloalkyl or hydroxyalkyl substituent, though it is unclear if this applies to pyridine where nitorgen is fully engaged by the ring.]
Effective 13 Jun 2012, S.I. 2012/1390 added:
On 28 Feb 2012, S.I. 2012/1390* proposed to add:
1(ac)
Any compound (not being Pipradrol structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,
  1. by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;
  2. by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;
  3. by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.
Barbituric acid
[Barbituric acid with the 5,5-disubstitution pattern. R1 and R2 are typically alkyl, alkenyl, bromoalkenyl, cycloalkenyl or phenyl groups.]
Effective 1 Jan 1985, S.I. 1984/859 added:
1(b)
Any 5,5-disubstituted Barbituric acid
CA: CDSA Schedule IV Section 1 Barbiturates
⇒
Wikipedia: Barbiturate
3D rendering of [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
Effective 23 Dec 2009, S.I. 2009/3209 added:
1(c)
[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
⇒
PubChem: 5689; ChemSpider: 5487; Bluelight: WIN 55,212-2; Wikipedia: WIN 55,212-2
3D rendering of 3-Dimethylheptyl-11-hydroxyhexahydrocannabinol
Effective 23 Dec 2009, S.I. 2009/3209 added:
3-Dimethylheptyl-11-hydroxyhexahydrocannabinol [sic]
The chemical name provided by the legislation seems dodgy. The structure shown is based on an alternative name, HU 243, mentioned in the Advisory Council on the Misuse of Drugs (ACMD) Consideration of the major cannabinoid agonists. This document provides a great overview of the wealth of synthetic cannabinoid recepter agonists. Curiously, parts of the report are redacted, “…on the ground that its publication would not be in the public interest.” Would that be the same “public interest” that led to the sacking of Dr. David Nutt, head of the ACMD?

L.A. King calls this name “technically incorrect.” He is being diplomatic. The correct name, he says, is: 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol. It’s pretty easy to see how mistakes like that happen.
⇒
PubChem: 44208947; ChemSpider: 24818295
3D rendering of [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
Effective 23 Dec 2009, S.I. 2009/3209 added:
[9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
⇒
Wikipedia: Levonantradol
3D rendering of 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Effective 23 Dec 2009, S.I. 2009/3209 added:
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
⇒
PubChem: 4193475; ChemSpider: 3404012; Wikipedia: HU-210
3D rendering of Nabilone
Effective 23 Dec 2009, S.I. 2009/3209 added:
Nabilone
CA: CDSA Schedule II Section 2 Subsection 1 Nabilone
US: CSA Schedule II Section f Subsection 1 Nabilone
⇒
PubChem: 5284592 39860; ChemSpider: 4447641; Wikipedia: Nabilone
3D rendering of 3-(1-Naphthoyl)indole
3-(1-Naphthoyl)indole
3D rendering of 3-(2-Naphthoyl)indole
3-(2-Naphthoyl)indole
3D rendering of 1H-Indol-3-yl-(1-naphthyl)methane
1H-Indol-3-yl-(1-naphthyl)methane
3D rendering of 1H-Indol-3-yl-(2-naphthyl)methane
1H-Indol-3-yl-(2-naphthyl)methane
Any compound structurally derived from 3-(1-Naphthoyl)indole, 3-(2-Naphthoyl)indole, 1H-Indol-3-yl-(1-naphthyl)methane or 1H-Indol-3-yl-(2-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Effective 26 Feb 2013, S.I. 2013/239 replacement for:
On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
Effective 23 Dec 2009, S.I. 2009/3209 added:
Any compound structurally derived from 3-(1-Naphthoyl)indole or 1H-Indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Special thanks to Nick for alerting me I had overlooked 3-(2-Naphthoyl)indole earlier. I always appreciate it when a reader reports an error or omission. Many eyes…
I looked without success for a representative of 3-(2-Naphthoyl)indole. The ACMD report has this telling rationale:
“In structures containing naphthoyl and adamantoyl groups, positional isomers may also be exploited and, as identification of a particular positional isomer could impose an unnecessary burden on forensic providers, we propose broadening the definitions of controlled compounds of these types to include all possible structures.”
It seems banning an infinite number of substances with totally unknown pharmacology is the price paid to avoid overburdening forensic providers. One hopes by this whim they have not forsaken, say, the next Viagra. Or something even more beneficial.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances controlled by the 3-(1-Naphthoyl)indole generic definition include: JWH-004, JWH-007, JWH-009, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-046, JWH-047, JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-180, JWH-181, JWH-182, JWH-189, JWH-193, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-262, JWH-386, JWH-387, JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414, JWH-415, AM-1220 and MAM-2201.
Substances controlled by the 1H-Indol-3-yl-(1-naphthyl)methane generic definition include: JWH-175, JWH-184, JWH-185, JWH-192, JWH-194, JWH-195, JWH-196, JWH-197 and JWH-199.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
CA: CDSA Schedule II Section 2 Subsection 2 3-(1-Naphthoyl)indole
US: CSA Schedule I Section ii Item ii 3-(1-Naphthoyl)indole
⇒
PubChem: 10355825; ChemSpider: 8531277
US: CSA Schedule I Section ii Item ii 3-(1-Naphthylmethane)indole
3D rendering of AM-2201
AM-2201
CA: CDSA Schedule II Section 2 Subsection 2 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 11 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole
⇒
PubChem: 53393997; ChemSpider: 24751884; Drugs Forum: AM-2201; Wikipedia: AM-2201
3D rendering of JWH-018
JWH-018
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
⇒
PubChem: 10382701; ChemSpider: 8558143; Bluelight: JWH-018; Drugs Forum: JWH-018; Erowid: Spice Product; Wikipedia: JWH-018
3D rendering of JWH-073
JWH-073
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
⇒
PubChem: 10471670; ChemSpider: 8647081; Bluelight: JWH-073; Erowid: Spice Product; Wikipedia: JWH-073
3D rendering of JWH-081
JWH-081
CA: CDSA Schedule II Section 2 Subsection 2 1-Butyl-3-(4-methoxy-1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 8 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole
⇒
PubChem: 10547208; ChemSpider: 8722599; Wikipedia: JWH-081
3D rendering of JWH-122
JWH-122
CA: CDSA Schedule II Section 2 Subsection 2 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
US: CSA Schedule I Section g Subsection 9 1-Pentyl-3-(4-methyl-1-naphthoyl)indole
⇒
PubChem: 44466638; ChemSpider: 24623066; Bluelight: JWH-122; Wikipedia: JWH-122
3D rendering of JWH-200
JWH-200
CA: CDSA Schedule II Section 2 Subsection 2 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole
US: CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
⇒
PubChem: 10045570; ChemSpider: 8221134; Drugs Forum: JWH-200; Erowid: Spice Product; Wikipedia: JWH-200
3D rendering of JWH-398
JWH-398
US: CSA Schedule I Section g Subsection 10 1-Pentyl-3-(4-chloro-1-naphthoyl)indole
⇒
PubChem: 57458928; ChemSpider: 28647395; Drugs Forum: JWH-398; Wikipedia: JWH-398
3D rendering of 3-(1-Naphthoyl)pyrrole
3-(1-Naphthoyl)pyrrole
3D rendering of 3-(2-Naphthoyl)pyrrole
3-(2-Naphthoyl)pyrrole
Any compound structurally derived from 3-(1-Naphthoyl)pyrrole or 3-(2-Naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Effective 26 Feb 2013, S.I. 2013/239 replacement for:
On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
Effective 23 Dec 2009, S.I. 2009/3209 added:
Any compound structurally derived from 3-(1-Naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances controlled by the 3-(1-Naphthoyl)pyrrole generic definition include: JWH-030, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373 and JWH-392.
CA: CDSA Schedule II Section 2 Subsection 3 3-(1-Naphthoyl)pyrrole
US: CSA Schedule I Section iii Item iii 3-(1-Naphthoyl)pyrrole
⇒
PubChem: 15832251; ChemSpider: 10506445
3D rendering of 1-(1-Naphthylmethylene)indene
1-(1-Naphthylmethylene)indene
3D rendering of 1-(2-Naphthylmethylene)indene
1-(2-Naphthylmethylene)indene
3D rendering of 1-(2-Naphthylmethyl)indene
1-(2-Naphthylmethyl)indene
Any compound structurally derived from 1-(1-Naphthylmethylene)indene or 1-(2-Naphthylmethylene)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
Effective 26 Feb 2013, S.I. 2013/239 replacement for:
On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
Effective 23 Dec 2009, S.I. 2009/3209 added:
Any compound structurally derived from 1-(1-Naphthylmethyl)indene[sic] by substitution at the 3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
This amendment discretely corrects a significant error in the existing nomenclature which mistakes “methyl” for “methylene.” See structures at left.
I doubt many convictions will be overturned by this blunder, but it seems to me that the substances meant to be captured by this paragraph had, in fact, escaped and remained at large until the amendment came into force.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances controlled by the 1-(1-Naphthylmethylene)indene generic definition include: JWH-176.
US: CSA Schedule I Section iv Item iv 1-(1-Naphthylmethylene)indene
3D rendering of 3-Phenylacetylindole
Any compound structurally derived from 3-Phenylacetylindole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Effective 26 Feb 2013, S.I. 2013/239 replacement for:
On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
Effective 23 Dec 2009, S.I. 2009/3209 added:
Any compound structurally derived from 3-Phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances controlled by the 3-Phenylacetylindole generic definition include: JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-249, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, and Cannabipiperidiethanone.
CA: CDSA Schedule II Section 2 Subsection 4 3-Phenylacetylindole
US: CSA Schedule I Section v Item v 3-Phenylacetylindole
⇒
PubChem: 266609; ChemSpider: 234313; Drugs Forum: Phenylacetylindoles
3D rendering of JWH-250
JWH-250
CA: CDSA Schedule II Section 2 Subsection 4 1-Pentyl-3-(2-methoxyphenylacetyl)indole
US: CSA Schedule I Section g Subsection 7 1-Pentyl-3-(2-methoxyphenylacetyl)indole
⇒
PubChem: 44397540; ChemSpider: 23256117; Drugs Forum: JWH-250; Wikipedia: JWH-250
3D rendering of RCS-8
RCS-8
US: CSA Schedule I Section g Subsection 14 1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole
⇒
PubChem: 53394099; ChemSpider: 24751863; Bluelight: RCS-8; Drugs Forum: RCS-8; Wikipedia: RCS-8
3D rendering of 2-(3-Hydroxycyclohexyl)phenol
Effective 23 Dec 2009, S.I. 2009/3209 added:
Any compound structurally derived from 2-(3-Hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances controlled by the 2-(3-Hydroxycyclohexyl)phenol generic definition include: CP-47-497, CP-55,940 and CP-56,667.
Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
US: CSA Schedule I Section i Item i 2-(3-Hydroxycyclohexyl)phenol
3D rendering of CP 47,497
CP 47,497
CA: CDSA Schedule II Section 2 Subsection 1 5-(1,1-Dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol
US: CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 15942731; ChemSpider: 10205286; Drugs Forum: CP 47,497; Erowid: Spice Product; Wikipedia: CP 47,497
3D rendering of CP 47,497-C8
CP 47,497-C8 (Cannabicyclohexanol)
US: CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
⇒
PubChem: 23986041; Erowid: Spice Product; Wikipedia: Cannabicyclohexanol
3D rendering of 3-Benzoylindole
Effective 26 Feb 2013, S.I. 2013/239 added:
On 8 Jan 2013, S.I. 2013/239* proposed to add:
Any compound structurally derived from 3-Benzoylindole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances potentially controlled by the 3-Benzoylindole generic definition include: AM-679, AM-694, AM-2233, RCS-4, RCS-4 (C4), RCS-2 (2-isomer) and WIN 48,098 (Pravadoline)
CA: CDSA Schedule II Section 2 Subsection 5 3-Benzoylindole
US: CSA Schedule I Section v Item v 3-Benzoylindole
⇒
PubChem: 84845; ChemSpider: 76537
3D rendering of AM-694
AM-694
US: CSA Schedule I Section g Subsection 12 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
⇒
PubChem: 9889172; ChemSpider: 8064843; Drugs Forum: AM-694; Wikipedia: AM-694
3D rendering of RCS-4
RCS-4
US: CSA Schedule I Section g Subsection 13 1-Pentyl-3-[(4-methoxy)-benzoyl]indole
See also MDA Part II Class B Section 1(c) RCS-4
⇒
PubChem: 56841530; ChemSpider: 24769418; Wikipedia: RCS-4; Wikipedia: RCS-4
3D rendering of RCS-4
RCS-4
US: CSA Schedule I Section g Subsection 13 1-Pentyl-3-[(4-methoxy)-benzoyl]indole
See also MDA Part II Class B Section 1(c) RCS-4
⇒
PubChem: 56841530; ChemSpider: 24769418; Wikipedia: RCS-4; Wikipedia: RCS-4
3D rendering of 3-(1-Adamantoyl)indole
3-(1-Adamantoyl)indole
3D rendering of 3-(2-Adamantoyl)indole
3-(2-Adamantoyl)indole
Effective 26 Feb 2013, S.I. 2013/239 added:
On 8 Jan 2013, S.I. 2013/239* proposed to add:
Any compound structurally derived from 3-(1-Adamantoyl)indole or 3-(2-Adamantoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances potentially controlled by the 3-(1-Adamantoyl)indole generic definition include: AB-001 and AM-1248.
3D rendering of 3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole
Effective 26 Feb 2013, S.I. 2013/239 added:
On 8 Jan 2013, S.I. 2013/239* proposed to add:
Any compound structurally derived from 3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent.
Please note that there are many, many substances controlled by this paragraph that are not listed below, and the absence of a substance from this tally should not be taken as an indication of legality.
Substances potentially controlled by the 3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole generic definition include: UR-144 and XLR-11.
3D rendering of UR-144
UR-144
CA: CDSA Schedule II Section 2 Subsection 6 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)-methanone
US: CSA Schedule I Section h Subsection 1 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 16 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone
⇒
PubChem: 44626619; ChemSpider: 24634882; Bluelight: UR-144; Drugs Forum: UR-144; Wikipedia: UR-144
3D rendering of XLR11
XLR11
CA: CDSA Schedule II Section 2 Subsection 6 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone
US: CSA Schedule I Section h Subsection 2 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
US: [proposed] CSA Schedule I Section g Subsection 17 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
⇒
PubChem: 57501498; ChemSpider: 28537382; Bluelight: XLR11; Wikipedia: XLR-11 (drug)
3D rendering of 1-Phenylcyclohexylamine
1-Phenylcyclohexylamine
3D rendering of 2-Amino-2-phenylcyclohexanone
2-Amino-2-phenylcyclohexanone
Effective 26 Feb 2013, S.I. 2013/239 added:
On 8 Jan 2013, S.I. 2013/239* proposed to add:
1(d)
1-Phenylcyclohexylamine or any compound (not being ketamine, tiletamine or a compound for the time being specified in paragraph 1(a) of Part 1 of this Schedule) structurally derived from 1-Phenylcyclohexylamine or 2-Amino-2-phenylcyclohexanone by modification in any of the following ways, that is to say, < ol>< li>by substitution at the nitrogen atom to any extent by alkyl, alkenyl or hydroxyalkyl groups, or replacement of the amino group with a 1-piperidyl, 1-pyrrolidyl or 1-azepyl group, whether or not the nitrogen containing ring is further substituted by one or more alkyl groups;
  • by substitution in the phenyl ring to any extent by amino, alkyl, hydroxy, alkoxy or halide substituents, whether or not further substituted in the phenyl ring to any extent
  • by substitution in the cyclohexyl or cyclohexanone ring by one or more alkyl substituents;
  • by replacement of the phenyl ring with a thienyl ring.
    • Listed below are some examples of substances explicitly controlled in other jurisdictions that are members of the group implicitly controlled by this generic definition.
    3D rendering of Methoxetamine
    Methoxetamine
    EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
    UK: Previously at MDA Temporary Class Drug Orders 2012 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
    ⇒
    PubChem: 52911279; ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
    3D rendering of 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
    1-[1-(4-Methylphenyl)cyclohexyl]piperidine
    CA: CDSA Schedule III Section 23 1-[1-(4-Methylphenyl)cyclohexyl]piperidine
    ⇒
    PubChem: 611754; ChemSpider: 531782
    3D rendering of 1-Phenyl-N-propylcyclohexanamine
    1-Phenyl-N-propylcyclohexanamine
    CA: CDSA Schedule III Section 15 1-Phenyl-N-propylcyclohexanamine
    ⇒
    PubChem: 599880; ChemSpider: 521518
    3D rendering of TCPy
    TCPy (1-[1-(2-Thienyl)cyclohexyl]pyrrolidine)
    US: CSA Schedule I Section d Subsection 35 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
    ⇒
    PubChem: 62764; ChemSpider: 56506
    3D rendering of 1-Benzofuran
    1-Benzofuran
    3D rendering of 2,3-Dihydro-1-benzofuran
    2,3-Dihydro-1-benzofuran
    3D rendering of 1H-Indole
    1H-Indole
    3D rendering of Indoline
    Indoline
    3D rendering of 1H-Indene
    1H-Indene
    3D rendering of Indane
    Indane
    Effective 10 Jun 2014, S.I. 2014/1106 added:
    On 5 Mar 2014, S.I. 2014/1106* proposed to add:
    1(e)
    Any compound (not being a compound for the time being specified in paragraph 1(ba) of Part 1 of this Schedule) structurally derived from 1-Benzofuran, 2,3-Dihydro-1-benzofuran, 1H-Indole, Indoline, 1H-Indene, or Indane by substitution in the 6-membered ring with a 2-ethylamino [sic] substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.
    3D rendering of 1-(Benzofuran-5-yl)-propan-2-amine
    1-(Benzofuran-5-yl)-propan-2-amine
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(Benzofuran-5-yl)-propan-2-amine
    ⇒
    PubChem: 9837232; ChemSpider: 8012953; Drugs Forum: 5-APB; Wikipedia: 5-APB
    3D rendering of 1-(Benzofuran-6-yl)-propan-2-amine
    1-(Benzofuran-6-yl)-propan-2-amine
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(Benzofuran-6-yl)-propan-2-amine
    ⇒
    PubChem: 9794343; ChemSpider: 7970110; Bluelight: 6-APB; Drugs Forum: 6-APB; Erowid: 6-APB; Wikipedia: 6-APB
    3D rendering of 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
    1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
    ⇒
    PubChem: 192601; ChemSpider: 167143; Drugs Forum: 5-APDB; Wikipedia: 5-APDB
    3D rendering of 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
    1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
    ⇒
    PubChem: 192599; ChemSpider: 167141; Wikipedia: 6-APDB
    3D rendering of 1-(1H-Indol-5-yl)-1-methylethylamine
    1-(1H-Indol-5-yl)-1-methylethylamine
    EU: Substances Substances 5-(2-Aminopropyl)indole
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(1H-Indol-5-yl)-1-methylethylamine
    ⇒
    PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
    3D rendering of 1-(1H-Indol-6-yl)-1-methylethylamine
    1-(1H-Indol-6-yl)-1-methylethylamine
    UK: Previously at MDA Temporary Class Drug Orders 2013 1-(1H-Indol-6-yl)-1-methylethylamine
    2
    Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.
    2A
    Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(ac), (c) or (d) of this Part of this Schedule.
    Effective 26 Feb 2013, S.I. 2013/239 replacement for:
    On 8 Jan 2013, S.I. 2013/239* proposed replacement for:
    Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(ac) or (c) of this Part of this Schedule.
    Effective 13 Jun 2012, S.I. 2012/1390 replacement for:
    On 28 Feb 2012, S.I. 2012/1390* proposed replacement for:
    Any ester or ether of cannabinol or of a cannabinol derivative or of a substance for the time being specified in paragraph 1(c) of this Part of this Schedule.
    Effective 23 Dec 2009, S.I. 2009/3209 replacement for:
    Effective 26 Jan 2009, S.I. 2008/3130 added:
    Any ester or ether of cannabinol or of a cannabinol derivative.
    3
    Any salt of a substance for the time being specified in paragraph 1, 2 or 2A of this Part of this Schedule.
    Effective 26 Jan 2009, S.I. 2008/3130 replacement for:
    Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.
    4
    Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.
    Part III Class C Drugs
    Source: L. A. King, Forensic Chemistry of Substance Misuse: A Guide to Drug Control, RSC Publishing, Cambridge, 2009
    1(a)
    The following substances and products, namely:
    3D rendering of Alprazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Alprazolam
    CA: CDSA Schedule IV Section 18 Subsection 1 Alprazolam
    UN: Psychotropics Schedule IV Alprazolam
    US: CSA Schedule IV Section c Subsection 2 Alprazolam
    ⇒
    PubChem: 2118; ChemSpider: 2034; Bluelight: Alprazolam; Drugs Forum: Alprazolam; Erowid: Alprazolam; Wikipedia: Alprazolam
    3D rendering of Amineptine
    Effective 28 Mar 2011, S.I. 2011/744 added:
    On 13 Jan 2011, S.I. 2011/744* proposed to add:
    Amineptine
    CA: CDSA Schedule III Section 32 Amineptine
    UN: Psychotropics Schedule II Amineptine
    ⇒
    PubChem: 34870; ChemSpider: 32091; Wikipedia: Amineptine
    3D rendering of Aminorex
    Effective 1 May 1998, S.I. 1998/750 added:
    Aminorex
    CA: CDSA Schedule III Section 27 Aminorex
    UN: Psychotropics Schedule IV Aminorex
    US: CSA Schedule I Section f Subsection 1 Aminorex
    ⇒
    PubChem: 16630; ChemSpider: 15767; Wikipedia: Aminorex
    3D rendering of Benzphetamine
    Benzphetamine
    CA: CDSA Schedule I Section 19 Subsection 17 Benzphetamine
    CA: [revoked] CDSA Schedule III Section 1 Subsection 18 Benzphetamine
    UN: Psychotropics Schedule IV Benzfetamine (Benzphetamine)
    US: CSA Schedule III Section b Subsection 2 Benzphetamine
    ⇒
    PubChem: 2341; ChemSpider: 2251; Wikipedia: Benzphetamine
    3D rendering of Bromazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Bromazepam
    CA: CDSA Schedule IV Section 18 Subsection 2 Bromazepam
    UN: Psychotropics Schedule IV Bromazepam
    US: CSA Schedule IV Section c Subsection 4 Bromazepam
    ⇒
    PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
    3D rendering of 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
    Effective 13 Jun 2012, S.I. 2012/1390 added:
    On 28 Feb 2012, S.I. 2012/1390* proposed to add:
    7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
    ⇒
    PubChem: 40113; ChemSpider: 36657; Bluelight: Phenazepam; Drugs Forum: Phenazepam; Erowid: Phenazepam; Wikipedia: Phenazepam
    3D rendering of Brotizolam
    Effective 1 May 1998, S.I. 1998/750 added:
    Brotizolam
    CA: CDSA Schedule IV Section 18 Subsection 2.1 Brotizolam
    UN: Psychotropics Schedule IV Brotizolam
    ⇒
    PubChem: 2451; ChemSpider: 2357; Wikipedia: Brotizolam
    3D rendering of Buprenorphine
    Effective 18 Sep 1989, S.I. 1989/1340 added:
    Buprenorphine
    CA: CDSA Schedule I Section 10 Subsection 1 Buprenorphine
    UN: Psychotropics Schedule III Buprenorphine
    US: CSA Schedule III Section e Subsection 2 Item i Buprenorphine
    ⇒
    PubChem: 40400 644073; ChemSpider: 559124; Bluelight: Buprenorphine; Drugs Forum: Buprenorphine; Erowid: Buprenorphine; Wikipedia: Buprenorphine
    3D rendering of Camazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Camazepam
    CA: CDSA Schedule IV Section 18 Subsection 3 Camazepam
    UN: Psychotropics Schedule IV Camazepam
    US: CSA Schedule IV Section c Subsection 5 Camazepam
    ⇒
    PubChem: 37367; ChemSpider: 34285; Wikipedia: Camazepam
    Effective 26 Jan 2009, S.I. 2008/3130 revoked:
    Effective 29 Jan 2004, S.I. 2003/3201 added:
    Cannabinol
    UK: Currently at MDA Part II Class B Section 1(a) Cannabinol
    Effective 26 Jan 2009, S.I. 2008/3130 revoked:
    Effective 29 Jan 2004, S.I. 2003/3201 added:
    Cannabinol derivatives
    UK: Currently at MDA Part II Class B Section 1(a) Cannabinol
    Effective 26 Jan 2009, S.I. 2008/3130 revoked:
    Effective 29 Jan 2004, S.I. 2003/3201 added:
    Cannabis and Cannabis resin
    UK: Currently at MDA Part II Class B Section 1(a) Cannabinol
    3D rendering of Cathine
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Cathine
    CA: CDSA Schedule IV Section 19 Subsection 1 Cathine
    UN: Psychotropics Schedule III Cathine ((+)-Norpseudoephedrine)
    US: CSA Schedule IV Section f Subsection 1 Cathine
    ⇒
    PubChem: 441457; ChemSpider: 390189; Drugs Forum: Khat; Erowid: Khat; Wikipedia: Cathine
    3D rendering of Cathinone
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Cathinone
    CA: CDSA Schedule III Section 19 Cathinone
    UN: Psychotropics Schedule I Cathinone
    US: CSA Schedule I Section f Subsection 3 Cathinone
    See also MDA Part II Class B Section 1(aa) Cathinone
    ⇒
    PubChem: 107786; ChemSpider: 96940; Erowid: Cathinone; Wikipedia: Cathinone
    3D rendering of Chlordiazepoxide
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Chlordiazepoxide
    CA: CDSA Schedule IV Section 18 Subsection 4 Chlordiazepoxide
    UN: Psychotropics Schedule IV Chlordiazepoxide
    US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
    ⇒
    PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
    3D rendering of Chlorphentermine
    Chlorphentermine
    CA: CDSA Schedule IV Section 3 Chlorphentermine
    US: CSA Schedule III Section b Subsection 3 Chlorphentermine
    ⇒
    PubChem: 10007; ChemSpider: 9613; Wikipedia: Chlorphentermine
    3D rendering of Clobazam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Clobazam
    CA: CDSA Schedule IV Section 18 Subsection 5 Clobazam
    UN: Psychotropics Schedule IV Clobazam
    US: CSA Schedule IV Section c Subsection 10 Clobazam
    ⇒
    PubChem: 2789; ChemSpider: 2687; Wikipedia: Clobazam
    3D rendering of Clonazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Clonazepam
    CA: CDSA Schedule IV Section 18 Subsection 6 Clonazepam
    UN: Psychotropics Schedule IV Clonazepam
    US: CSA Schedule IV Section c Subsection 11 Clonazepam
    ⇒
    PubChem: 2802; ChemSpider: 2700; Bluelight: Clonazepam; Drugs Forum: Clonazepam; Erowid: Clonazepam; Wikipedia: Clonazepam
    3D rendering of Clorazepic acid
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Clorazepic acid
    CA: CDSA Schedule IV Section 18 Subsection 7 Clorazepate
    UN: Psychotropics Schedule IV Clorazepate
    US: CSA Schedule IV Section c Subsection 12 Clorazepate
    ⇒
    PubChem: 2809; ChemSpider: 2707; Wikipedia: Clorazepate
    3D rendering of Clotiazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Clotiazepam
    CA: CDSA Schedule IV Section 12 Clotiazepam
    UN: Psychotropics Schedule IV Clotiazepam
    US: CSA Schedule IV Section c Subsection 13 Clotiazepam
    ⇒
    PubChem: 2811; ChemSpider: 2709; Wikipedia: Clotiazepam
    3D rendering of Cloxazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Cloxazolam
    CA: CDSA Schedule IV Section 18 Subsection 8 Cloxazolam
    UN: Psychotropics Schedule IV Cloxazolam
    US: CSA Schedule IV Section c Subsection 14 Cloxazolam
    ⇒
    PubChem: 2816; ChemSpider: 2714; Wikipedia: Cloxazolam
    3D rendering of Delorazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Delorazepam
    CA: CDSA Schedule IV Section 18 Subsection 9 Delorazepam
    UN: Psychotropics Schedule IV Delorazepam
    US: CSA Schedule IV Section c Subsection 15 Delorazepam
    ⇒
    PubChem: 17925; ChemSpider: 16929; Wikipedia: Delorazepam
    3D rendering of Dextropropoxyphene
    Effective 18 Jul 1983, S.I. 1983/765 added:
    Dextropropoxyphene
    CA: CDSA Schedule I Section 7 Subsection 3 Dextropropoxyphene
    UN: Narcotics Part 1 Section 2 Dextropropoxyphene and Part 2 Section 3 Dextropropoxyphene
    US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
    ⇒
    PubChem: 10100; ChemSpider: 9696; Wikipedia: Dextropropoxyphene
    3D rendering of Diazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Diazepam
    CA: CDSA Schedule IV Section 18 Subsection 10 Diazepam
    UN: Psychotropics Schedule IV Diazepam
    US: CSA Schedule IV Section c Subsection 16 Diazepam
    ⇒
    PubChem: 3016; ChemSpider: 2908; Bluelight: Diazepam; Drugs Forum: Diazepam; Erowid: Diazepam; Wikipedia: Diazepam
    3D rendering of Diethylpropion
    Effective 1 Jan 1985, S.I. 1984/859 added:
    Diethylpropion
    CA: CDSA Schedule IV Section 4 Diethylpropion
    UN: Psychotropics Schedule IV Amfepramone (Diethylpropion)
    US: CSA Schedule IV Section f Subsection 2 Diethylpropion
    See also MDA Part II Class B Section 1(aa) Diethylpropion
    ⇒
    PubChem: 7029; ChemSpider: 6762; Wikipedia: Amfepramone
    3D rendering of Estazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Estazolam
    CA: CDSA Schedule IV Section 18 Subsection 11 Estazolam
    UN: Psychotropics Schedule IV Estazolam
    US: CSA Schedule IV Section c Subsection 18 Estazolam
    ⇒
    PubChem: 3261; ChemSpider: 3146; Wikipedia: Estazolam
    3D rendering of Ethchlorvynol
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Ethchlorvynol
    CA: CDSA Schedule IV Section 13 Ethchlorvynol
    UN: Psychotropics Schedule IV Ethchlorvynol
    US: CSA Schedule IV Section c Subsection 19 Ethchlorvynol
    ⇒
    PubChem: 5281077; ChemSpider: 4444534; Erowid: Ethchlorvynol; Wikipedia: Ethchlorvynol
    3D rendering of Ethinamate
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Ethinamate
    CA: CDSA Schedule IV Section 14 Ethinamate
    UN: Psychotropics Schedule IV Ethinamate
    US: CSA Schedule IV Section c Subsection 20 Ethinamate
    ⇒
    PubChem: 3284; ChemSpider: 3169; Wikipedia: Ethinamate
    3D rendering of Ethyl loflazepate
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Ethyl loflazepate
    CA: CDSA Schedule IV Section 18 Subsection 12 Ethyl loflazepate
    UN: Psychotropics Schedule IV Ethyl loflazepate
    US: CSA Schedule IV Section c Subsection 21 Ethyl loflazepate
    ⇒
    PubChem: 3299; ChemSpider: 3183; Wikipedia: Ethyl loflazepate
    3D rendering of Fencamfamin
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Effective 1 Jul 1973, S.I. 1973/771 revoked:
    Fencamfamin
    CA: CDSA Schedule IV Section 20 Fencamfamin
    UN: Psychotropics Schedule IV Fencamfamin
    US: CSA Schedule IV Section f Subsection 3 Fencamfamin
    ⇒
    PubChem: 14584; ChemSpider: 13922; Wikipedia: Fencamfamine
    3D rendering of Fenethylline
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Fenethylline
    CA: CDSA Schedule III Section 20 Fenetylline
    UN: Psychotropics Schedule II Fenetylline
    US: CSA Schedule I Section f Subsection 4 Fenethylline
    ⇒
    PubChem: 19527; ChemSpider: 18398; Wikipedia: Fenethylline
    3D rendering of Fenproporex
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Fenproporex
    CA: CDSA Schedule IV Section 21 Fenproporex
    UN: Psychotropics Schedule IV Fenproporex
    US: CSA Schedule IV Section f Subsection 4 Fenproporex
    ⇒
    PubChem: 61810; ChemSpider: 55690; Wikipedia: Fenproporex
    3D rendering of Fludiazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Fludiazepam
    CA: CDSA Schedule IV Section 18 Subsection 13 Fludiazepam
    UN: Psychotropics Schedule IV Fludiazepam
    US: CSA Schedule IV Section c Subsection 22 Fludiazepam
    ⇒
    PubChem: 3369; ChemSpider: 3252; Wikipedia: Fludiazepam
    3D rendering of Flunitrazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Flunitrazepam
    CA: CDSA Schedule I Section 20 Flunitrazepam
    CA: [revoked] CDSA Schedule III Section 25 Flunitrazepam
    UN: Psychotropics Schedule III Flunitrazepam
    US: CSA Schedule IV Section c Subsection 23 Flunitrazepam
    ⇒
    PubChem: 3380; ChemSpider: 3263; Drugs Forum: Flunitrazepam; Erowid: Flunitrazepam; Wikipedia: Flunitrazepam
    3D rendering of Flurazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Flurazepam
    CA: CDSA Schedule IV Section 18 Subsection 15 Flurazepam
    UN: Psychotropics Schedule IV Flurazepam
    US: CSA Schedule IV Section c Subsection 24 Flurazepam
    ⇒
    PubChem: 3393; ChemSpider: 3276; Erowid: Flurazepam; Wikipedia: Flurazepam
    3D rendering of Gamma-butyrolactone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Gamma-butyrolactone
    CA: CDSA Schedule VI Part 1 Subsection 18 Gamma-butyrolactone
    US: CSA Listed Chemicals Section a Subsection 24 Gamma-butyrolactone
    ⇒
    PubChem: 7302; ChemSpider: 7029; Drugs Forum: GBL; Wikipedia: gamma-Butyrolactone
    3D rendering of Halazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Halazepam
    CA: CDSA Schedule IV Section 18 Subsection 16 Halazepam
    UN: Psychotropics Schedule IV Halazepam
    US: CSA Schedule IV Section c Subsection 26 Halazepam
    ⇒
    PubChem: 31640; ChemSpider: 29343; Wikipedia: Halazepam
    3D rendering of Haloxazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Haloxazolam
    CA: CDSA Schedule IV Section 18 Subsection 17 Haloxazolam
    UN: Psychotropics Schedule IV Haloxazolam
    US: CSA Schedule IV Section c Subsection 27 Haloxazolam
    ⇒
    PubChem: 3563; ChemSpider: 3442; Wikipedia: Haloxazolam
    3D rendering of 4-Hydroxy-n-butyric acid
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    4-Hydroxy-n-butyric acid
    CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
    CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
    UN: Psychotropics Schedule II GHB
    UN: [revoked] Psychotropics Schedule IV GHB
    US: CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid and Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
    ⇒
    PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
    3D rendering of Ketamine
    Effective 10 Jun 2014, S.I. 2014/1106 revoked:
    On 5 Mar 2014, S.I. 2014/1106* proposed to revoke:
    Effective 1 Jan 2006, S.I. 2005/3178 added:
    Ketamine
    CA: CDSA Schedule I Section 14 Subsection 1 Ketamine
    US: CSA Schedule III Section c Subsection 7 Ketamine
    See also MDA Part II Class B Section 1(a) Ketamine
    ⇒
    PubChem: 3821; ChemSpider: 3689; Bluelight: Ketamine; Bluelight: Ketamine; Drugs Forum: Ketamine; Erowid: Ketamine; Wikipedia: Ketamine
    3D rendering of Ketazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Ketazolam
    CA: CDSA Schedule IV Section 18 Subsection 18 Ketazolam
    UN: Psychotropics Schedule IV Ketazolam
    US: CSA Schedule IV Section c Subsection 28 Ketazolam
    ⇒
    PubChem: 33746; ChemSpider: 31110; Wikipedia: Ketazolam
    Effective 24 Jun 2014, S.I. 2014/1352 added:
    On 5 Nov 2013, S.I. 2013/1352* proposed to add:
    Khat
    CA: CDSA Schedule IV Section 19 Catha edulis
    ⇒
    Drugs Forum: Khat; Wikipedia: Khat
    3D rendering of Loprazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Loprazolam
    CA: CDSA Schedule IV Section 18 Subsection 19 Loprazolam
    UN: Psychotropics Schedule IV Loprazolam
    US: CSA Schedule IV Section c Subsection 29 Loprazolam
    ⇒
    PubChem: 3033860; ChemSpider: 2298440; Wikipedia: Loprazolam
    3D rendering of Lorazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Lorazepam
    CA: CDSA Schedule IV Section 18 Subsection 20 Lorazepam
    UN: Psychotropics Schedule IV Lorazepam
    US: CSA Schedule IV Section c Subsection 30 Lorazepam
    ⇒
    PubChem: 3958; ChemSpider: 3821; Bluelight: Lorazepam; Drugs Forum: Lorazepam; Erowid: Lorazepam; Wikipedia: Lorazepam
    3D rendering of Lormetazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Lormetazepam
    CA: CDSA Schedule IV Section 18 Subsection 21 Lormetazepam
    UN: Psychotropics Schedule IV Lormetazepam
    US: CSA Schedule IV Section c Subsection 31 Lormetazepam
    ⇒
    PubChem: 13314; ChemSpider: 12750; Drugs Forum: Lormetazepam; Wikipedia: Lormetazepam
    3D rendering of Mazindol
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Mazindol
    CA: CDSA Schedule IV Section 15 Mazindol
    UN: Psychotropics Schedule IV Mazindol
    US: CSA Schedule IV Section f Subsection 5 Mazindol
    ⇒
    PubChem: 4020; ChemSpider: 3880; Wikipedia: Mazindol
    3D rendering of Medazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Medazepam
    CA: CDSA Schedule IV Section 18 Subsection 22 Medazepam
    UN: Psychotropics Schedule IV Medazepam
    US: CSA Schedule IV Section c Subsection 33 Medazepam
    ⇒
    PubChem: 4041; ChemSpider: 3901; Wikipedia: Medazepam
    3D rendering of Mefenorex
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Mefenorex
    CA: CDSA Schedule IV Section 22 Mefenorex
    UN: Psychotropics Schedule IV Mefenorex
    US: CSA Schedule IV Section f Subsection 6 Mefenorex
    ⇒
    PubChem: 21777; ChemSpider: 20467; Wikipedia: Mefenorex
    3D rendering of Mephentermine
    Mephentermine
    ⇒
    PubChem: 3677; ChemSpider: 3549; Wikipedia: Mephentermine
    Effective 1 Jan 1985, S.I. 1984/859 revoked:
    Methaqualone
    UK: Currently at MDA Part II Class B Section 1(a) Methaqualone
    3D rendering of Meprobamate
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Meprobamate
    CA: CDSA Schedule IV Section 16 Meprobamate
    UN: Psychotropics Schedule IV Meprobamate
    US: CSA Schedule IV Section c Subsection 34 Meprobamate
    ⇒
    PubChem: 4064; ChemSpider: 3924; Wikipedia: Meprobamate
    3D rendering of Mesocarb
    Effective 1 May 1998, S.I. 1998/750 added:
    Mesocarb
    CA: CDSA Schedule III Section 30 Mesocarb
    UN: Psychotropics Schedule IV Mesocarb
    ⇒
    PubChem: 71932; ChemSpider: 64942; Wikipedia: Mesocarb
    3D rendering of Methyprylone
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Methyprylone
    CA: CDSA Schedule IV Section 17 Methyprylon
    UN: Psychotropics Schedule IV Methyprylon
    US: CSA Schedule III Section c Subsection 10 Methyprylon
    ⇒
    PubChem: 4162; ChemSpider: 4018; Wikipedia: Methyprylon
    3D rendering of Midazolam
    Effective 1 Feb 1990, S.I. 1990/2589 added:
    Midazolam
    CA: CDSA Schedule IV Section 18 Subsection 22.1 Midazolam
    UN: Psychotropics Schedule IV Midazolam
    US: CSA Schedule IV Section c Subsection 37 Midazolam
    ⇒
    PubChem: 4192; ChemSpider: 4047; Drugs Forum: Midazolam; Wikipedia: Midazolam
    3D rendering of Nimetazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Nimetazepam
    CA: CDSA Schedule IV Section 18 Subsection 23 Nimetazepam
    UN: Psychotropics Schedule IV Nimetazepam
    US: CSA Schedule IV Section c Subsection 38 Nimetazepam
    ⇒
    PubChem: 4496; ChemSpider: 4340; Drugs Forum: Nimetazepam; Erowid: Nimetazepam; Wikipedia: Nimetazepam
    3D rendering of Nitrazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Nitrazepam
    CA: CDSA Schedule IV Section 18 Subsection 24 Nitrazepam
    UN: Psychotropics Schedule IV Nitrazepam
    US: CSA Schedule IV Section c Subsection 39 Nitrazepam
    ⇒
    PubChem: 4506; ChemSpider: 4350; Drugs Forum: Nitrazepam; Erowid: Nitrazepam Synthesis; Wikipedia: Nitrazepam
    3D rendering of Nordazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Nordazepam
    CA: CDSA Schedule IV Section 18 Subsection 25 Nordazepam
    UN: Psychotropics Schedule IV Nordazepam
    US: CSA Schedule IV Section c Subsection 40 Nordiazepam
    ⇒
    PubChem: 2997; ChemSpider: 2890; Bluelight: Nordiazepam ; Erowid: Nordiazepam Synthesis; Wikipedia: Nordazepam
    3D rendering of Oxazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Oxazepam
    CA: CDSA Schedule IV Section 18 Subsection 26 Oxazepam
    UN: Psychotropics Schedule IV Oxazepam
    US: CSA Schedule IV Section c Subsection 41 Oxazepam
    ⇒
    PubChem: 4616; ChemSpider: 4455; Bluelight: Oxazepam; Drugs Forum: Oxazepam; Wikipedia: Oxazepam
    3D rendering of Oxazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Oxazolam
    CA: CDSA Schedule IV Section 18 Subsection 27 Oxazolam
    UN: Psychotropics Schedule IV Oxazolam
    US: CSA Schedule IV Section c Subsection 42 Oxazolam
    ⇒
    PubChem: 4617; ChemSpider: 4456; Wikipedia: Oxazolam
    3D rendering of Pemoline
    Effective 18 Sep 1989, S.I. 1989/1340 added:
    Effective 1 Jul 1973, S.I. 1973/771 revoked:
    Pemoline
    CA: CDSA Schedule IV Section 25.1 Pemoline
    UN: Psychotropics Schedule IV Pemoline
    US: CSA Schedule IV Section f Subsection 8 Pemoline
    ⇒
    PubChem: 4723; ChemSpider: 4561; Drugs Forum: Pemoline ; Erowid: Pemoline Synthesis; Wikipedia: Pemoline
    3D rendering of Phendimetrazine
    Phendimetrazine
    CA: CDSA Schedule IV Section 5 Phendimetrazine
    UN: Psychotropics Schedule IV Phendimetrazine
    US: CSA Schedule III Section b Subsection 5 Phendimetrazine
    ⇒
    PubChem: 12460; ChemSpider: 11950; Drugs Forum: Phendimetrazine; Wikipedia: Phendimetrazine
    3D rendering of Phentermine
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Effective 1 Jul 1973, S.I. 1973/771 revoked:
    Phentermine
    CA: CDSA Schedule IV Section 8 Phentermine
    UN: Psychotropics Schedule IV Phentermine
    US: CSA Schedule IV Section f Subsection 9 Phentermine
    ⇒
    PubChem: 4771; ChemSpider: 4607; Drugs Forum: Phentermine; Wikipedia: Phentermine
    3D rendering of Pinazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Pinazepam
    CA: CDSA Schedule IV Section 18 Subsection 28 Pinazepam
    UN: Psychotropics Schedule IV Pinazepam
    US: CSA Schedule IV Section c Subsection 46 Pinazepam
    ⇒
    PubChem: 40391; ChemSpider: 36899; Drugs Forum: Pinazepam; Wikipedia: Pinazepam
    Effective 13 Jun 2012, S.I. 2012/1390 revoked:
    On 28 Feb 2012, S.I. 2012/1390* proposed to revoke:
    Pipradrol
    UK: Currently at MDA Part III Class C Section 1(b) Pipradrol
    3D rendering of Prazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Prazepam
    CA: CDSA Schedule IV Section 18 Subsection 29 Prazepam
    UN: Psychotropics Schedule IV Prazepam
    US: CSA Schedule IV Section c Subsection 47 Prazepam
    ⇒
    PubChem: 4890; ChemSpider: 4721; Wikipedia: Prazepam
    Effective 1 Jul 1973, S.I. 1973/771 revoked:
    Prolintane
    Effective 1 Sep 1995, S.I. 1995/1966 revoked:
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Propylhexedrine
    3D rendering of Pyrovalerone
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    Pyrovalerone
    CA: CDSA Schedule IV Section 26 Pyrovalerone
    UN: Psychotropics Schedule IV Pyrovalerone
    US: CSA Schedule V Section d Subsection 1 Pyrovalerone
    See also MDA Part II Class B Section 1(aa) Pyrovalerone
    ⇒
    PubChem: 14373; ChemSpider: 13733; Wikipedia: Pyrovalerone
    3D rendering of Temazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Temazepam
    CA: CDSA Schedule IV Section 18 Subsection 30 Temazepam
    UN: Psychotropics Schedule IV Temazepam
    US: CSA Schedule IV Section c Subsection 50 Temazepam
    ⇒
    PubChem: 5391; ChemSpider: 5198; Bluelight: Temazepam; Drugs Forum: Temazepam; Erowid: Temazepam; Wikipedia: Temazepam
    3D rendering of Tetrazepam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Tetrazepam
    CA: CDSA Schedule IV Section 18 Subsection 31 Tetrazepam
    UN: Psychotropics Schedule IV Tetrazepam
    US: CSA Schedule IV Section c Subsection 51 Tetrazepam
    ⇒
    PubChem: 25215; ChemSpider: 23551; Bluelight: Tetrazepam; Drugs Forum: Tetrazepam; Wikipedia: Tetrazepam
    3D rendering of Tramadol
    Effective 10 Jun 2014, S.I. 2014/1106 added:
    On 5 Mar 2014, S.I. 2014/1106* proposed to add:
    Tramadol
    CA: [proposed] CDSA Schedule I Section 18.5 Tramadol
    US: CSA Schedule IV Section b Subsection 3
    ⇒
    PubChem: 33741; ChemSpider: 31105; Drugs Forum: Tramadol; Erowid: Tramadol; Wikipedia: Tramadol
    3D rendering of Triazolam
    Effective 1 Apr 1986, S.I. 1985/1995 added:
    Triazolam
    CA: CDSA Schedule IV Section 18 Subsection 32 Triazolam
    UN: Psychotropics Schedule IV Triazolam
    US: CSA Schedule IV Section c Subsection 52 Triazolam
    ⇒
    PubChem: 5556; ChemSpider: 5355; Bluelight: Triazolam; Drugs Forum: Triazolam; Erowid: Triazolam; Wikipedia: Triazolam
    3D rendering of N-Ethylamphetamine
    Effective 1 Apr 1987, S.I. 1986/2230 added:
    N-Ethylamphetamine
    CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
    CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
    UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
    US: CSA Schedule I Section f Subsection 7 N-Ethylamphetamine
    ⇒
    PubChem: 9982; ChemSpider: 9588; Wikipedia: Ethylamphetamine
    3D rendering of Zaleplon
    Effective 10 Jun 2014, S.I. 2014/1106 added:
    On 5 Mar 2014, S.I. 2014/1106* proposed to add:
    Zaleplon
    US: CSA Schedule IV Section c Subsection 53 Zaleplon
    ⇒
    PubChem: 5719; ChemSpider: 5517; Bluelight: Zaleplon; Drugs Forum: Zaleplon; Erowid: Zaleplon; Wikipedia: Zaleplon
    3D rendering of Zolpidem
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    Zolpidem
    CA: CDSA Schedule IV Section 25 Zolpidem
    UN: Psychotropics Schedule IV Zolpidem
    US: CSA Schedule IV Section c Subsection 54 Zolpidem
    ⇒
    PubChem: 5732; ChemSpider: 5530; Bluelight: Zolpidem; Drugs Forum: Zolpidem; Erowid: Zolpidem; Wikipedia: Zolpidem
    3D rendering of Zopiclone
    Effective 10 Jun 2014, S.I. 2014/1106 added:
    On 5 Mar 2014, S.I. 2014/1106* proposed to add:
    Zopiclone
    US: CSA Schedule IV Section c Subsection 55 Zopiclone
    ⇒
    PubChem: 5735; ChemSpider: 5533; Bluelight: Zopiclone; Drugs Forum: Zopiclone; Erowid: Zopiclone; Wikipedia: Zopiclone
    Readers wanting to explore the intricacies of steroid nomenclature may find this steroid crib sheet useful.
    3D rendering of 5α-Androstane-3,17-diol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    1(b)
    5α-Androstane-3,17-diol
    US: CSA Schedule III Section f Subsection 1 Item 2 3α,17β-Dihydroxy-5α-androstane
    ⇒
    PubChem: 15818; ChemSpider: 15039; Erowid: Steroids
    3D rendering of Androst-4-ene-3,17-diol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Androst-4-ene-3,17-diol
    US: CSA Schedule III Section f Subsection 1 Item 6 4-Androstenediol
    ⇒
    PubChem: 136297; ChemSpider: 120071; Erowid: Steroids; Wikipedia: 4-Androstenediol
    3D rendering of 1-Androstenediol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    1-Androstenediol
    US: CSA Schedule III Section f Subsection 1 Item 5 1-Androstenediol
    ⇒
    PubChem: 11300765; ChemSpider: 9635329; Erowid: Steroids
    3D rendering of 1-Androstenedione
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    1-Androstenedione
    US: CSA Schedule III Section f Subsection 1 Item 8 1-Androstenedione
    ⇒
    PubChem: 11196935; ChemSpider: 9372004; Erowid: Steroids; Wikipedia: 1-Androstenedione
    3D rendering of 4-Androstene-3,17-dione
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    4-Androstene-3,17-dione
    US: CSA Schedule III Section f Subsection 1 Item 9 4-Androstenedione
    ⇒
    PubChem: 6128; ChemSpider: 5898; Erowid: Steroids; Wikipedia: Androstenedione
    3D rendering of 5-Androstenedione
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    5-Androstenedione
    US: CSA Schedule III Section f Subsection 1 Item 10 5-Androstenedione
    ⇒
    PubChem: 160531; ChemSpider: 141063; Erowid: Steroids; Wikipedia: 5-Androstenedione
    3D rendering of 5-Androstene-3,17-diol
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    5-Androstene-3,17-diol
    CA: CDSA Schedule IV Section 23 Subsection 3 Androstenediol
    US: CSA Schedule III Section f Subsection 1 Item 7 5-Androstenediol
    ⇒
    PubChem: 10634; ChemSpider: 10188; Erowid: Steroids; Wikipedia: 5-Androstenediol
    3D rendering of Atamestane
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Atamestane
    ⇒
    PubChem: 57050; ChemSpider: 51438; Wikipedia: Atamestane
    3D rendering of Bolandiol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Bolandiol
    CA: CDSA Schedule IV Section 23 Subsection 4 Bolandiol
    US: CSA Schedule III Section f Subsection 1 Item 44 19-Nor-4-androstenediol
    ⇒
    PubChem: 9835303; ChemSpider: 8011024; Erowid: Steroids; Wikipedia: Bolandiol
    3D rendering of Bolasterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Bolasterone
    CA: CDSA Schedule IV Section 23 Subsection 5 Bolasterone
    US: CSA Schedule III Section f Subsection 1 Item 11 Bolasterone
    ⇒
    PubChem: 102146; ChemSpider: 92280; Erowid: Steroids; Wikipedia: Bolasterone
    3D rendering of Bolazine
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Bolazine
    CA: CDSA Schedule IV Section 23 Subsection 6 Bolazine
    ⇒
    PubChem: 20055426 16396252 10348670 4594169; ChemSpider: 16736833; Wikipedia: Bolazine
    3D rendering of Boldenone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Boldenone
    CA: CDSA Schedule IV Section 23 Subsection 7 Boldenone
    US: CSA Schedule III Section f Subsection 1 Item 12 Boldenone
    ⇒
    PubChem: 13308; ChemSpider: 12744; Erowid: Steroids; Wikipedia: Boldenone
    3D rendering of Boldione
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Boldione
    US: CSA Schedule III Section f Subsection 1 Item 13 Boldione
    ⇒
    PubChem: 13472; ChemSpider: 12893; Erowid: Steroids; Wikipedia: Boldione
    3D rendering of Bolenol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Bolenol
    CA: CDSA Schedule IV Section 23 Subsection 8 Bolenol
    ⇒
    PubChem: 21140722 20055427 11954311; ChemSpider: 10128606; Wikipedia: Bolenol
    3D rendering of Bolmantalate
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Bolmantalate
    ⇒
    PubChem: 11954312; ChemSpider: 10128607
    3D rendering of 1,4-Butanediol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    1,4-Butanediol
    CA: CDSA Schedule VI Part 1 Subsection 19 1,4-Butanediol
    ⇒
    PubChem: 8064; ChemSpider: 13835209; Drugs Forum: 1,4-Butanediol; Erowid: 1,4-Butanediol; Wikipedia: 1,4-Butanediol
    3D rendering of Calusterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Calusterone
    CA: CDSA Schedule IV Section 23 Subsection 9 Calusterone
    US: CSA Schedule III Section f Subsection 1 Item 14 Calusterone
    ⇒
    PubChem: 28204; ChemSpider: 26239; Erowid: Steroids; Wikipedia: Calusterone
    3D rendering of 4-Chloromethandienone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    4-Chloromethandienone
    US: CSA Schedule III Section f Subsection 1 Item 16 Dehydrochloromethyltestosterone
    ⇒
    PubChem: 16395944; ChemSpider: 88972; Erowid: Steroids; Wikipedia: 4-Chlorodehydromethyltestosterone
    3D rendering of Clostebol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Clostebol
    CA: CDSA Schedule IV Section 23 Subsection 10 Clostebol
    US: CSA Schedule III Section f Subsection 1 Item 15 Clostebol
    ⇒
    PubChem: 68947; ChemSpider: 62171; Erowid: Steroids; Wikipedia: Clostebol
    3D rendering of Danazol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Danazol
    ⇒
    PubChem: 667474 16757656 11957530 11874041 11869648 11416460 7078889 7061279 6540825 28417; ChemSpider: 26436; Wikipedia: Danazol
    3D rendering of Desoxymethyltestosterone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Desoxymethyltestosterone
    US: CSA Schedule III Section f Subsection 1 Item 17 Desoxymethyltestosterone
    ⇒
    PubChem: 18651; ChemSpider: 17611; Erowid: Steroids; Wikipedia: Desoxymethyltestosterone
    3D rendering of Drostanolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Drostanolone
    CA: CDSA Schedule IV Section 23 Subsection 11 Drostanolone
    US: CSA Schedule III Section f Subsection 1 Item 20 Drostanolone
    ⇒
    PubChem: 6011; ChemSpider: 5789; Erowid: Steroids; Wikipedia: Drostanolone
    3D rendering of Enestebol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Enestebol
    CA: CDSA Schedule IV Section 23 Subsection 12 Enestebol
    ⇒
    PubChem: 208919; ChemSpider: 16736606; Wikipedia: Enestebol
    3D rendering of Epitiostanol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Epitiostanol
    CA: CDSA Schedule IV Section 23 Subsection 13 Epitiostanol
    ⇒
    PubChem: 57168634 443935 9875022 6713995; ChemSpider: 391989; Wikipedia: Epitiostanol
    3D rendering of Ethyloestrenol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Ethyloestrenol
    CA: CDSA Schedule IV Section 23 Subsection 14 Ethylestrenol
    US: CSA Schedule III Section f Subsection 1 Item 21 Ethylestrenol
    ⇒
    PubChem: 13765; ChemSpider: 13168; Erowid: Steroids; Wikipedia: Ethylestrenol
    3D rendering of Fluoxymesterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Fluoxymesterone
    CA: CDSA Schedule IV Section 23 Subsection 16 Fluoxymesterone
    US: CSA Schedule III Section f Subsection 1 Item 22 Fluoxymesterone
    ⇒
    PubChem: 6446; ChemSpider: 6205; Erowid: Steroids; Wikipedia: Fluoxymesterone
    3D rendering of Formebolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Formebolone
    CA: CDSA Schedule IV Section 23 Subsection 17 Formebolone
    US: CSA Schedule III Section f Subsection 1 Item 23 Formebolone
    ⇒
    PubChem: 17150; ChemSpider: 16234; Erowid: Steroids; Wikipedia: Formebolone
    3D rendering of Furazabol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Furazabol
    CA: CDSA Schedule IV Section 23 Subsection 18 Furazabol
    US: CSA Schedule III Section f Subsection 1 Item 24 Furazabol
    ⇒
    PubChem: 14708; ChemSpider: 14032; Erowid: Steroids; Wikipedia: Furazabol
    3D rendering of Gestrinone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Gestrinone
    ⇒
    PubChem: 44450258 27812; ChemSpider: 25877; Wikipedia: Gestrinone
    3D rendering of 3-Hydroxy-5α-androstan-17-one
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    3-Hydroxy-5α-androstan-17-one
    ⇒
    PubChem: 57285837 57215542 441302 56729943 56605132 49791162 25322974 25322973 24131069 23729586 16401171 167; ChemSpider: 5668
    3D rendering of Mebolazine
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mebolazine
    CA: CDSA Schedule IV Section 23 Subsection 19 Mebolazine
    ⇒
    PubChem: 9571069; ChemSpider: 16736946; Wikipedia: Mebolazine
    3D rendering of Mepitiostane
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mepitiostane
    ⇒
    PubChem: 30605; ChemSpider: 8084854; Wikipedia: Mepitiostane
    3D rendering of Mesabolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mesabolone
    CA: CDSA Schedule IV Section 23 Subsection 20 Mesabolone
    ⇒
    PubChem: 252294 1551217; ChemSpider: 221051; Wikipedia: Mesabolone
    3D rendering of Mestanolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mestanolone
    US: CSA Schedule III Section f Subsection 1 Item 28 Mestanolone
    ⇒
    PubChem: 10633; ChemSpider: 10187; Erowid: Steroids; Wikipedia: Mestanolone
    3D rendering of Mesterolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mesterolone
    CA: CDSA Schedule IV Section 23 Subsection 21 Mesterolone
    US: CSA Schedule III Section f Subsection 1 Item 29 Mesterolone
    ⇒
    PubChem: 15020; ChemSpider: 14296; Erowid: Steroids; Wikipedia: Mesterolone
    3D rendering of Methandienone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Methandienone
    CA: CDSA Schedule IV Section 23 Subsection 22 Metandienone
    US: CSA Schedule III Section f Subsection 1 Item 30 Methandienone
    ⇒
    PubChem: 6300; ChemSpider: 6061; Erowid: Steroids; Wikipedia: Methandrostenolone
    3D rendering of Methandriol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Methandriol
    CA: CDSA Schedule IV Section 23 Subsection 24 Methandriol
    US: CSA Schedule III Section f Subsection 1 Item 31 Methandriol
    ⇒
    PubChem: 10632; ChemSpider: 199375; Erowid: Steroids; Wikipedia: Methandriol
    3D rendering of Methenolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Methenolone
    CA: CDSA Schedule IV Section 23 Subsection 23 Metenolone
    US: CSA Schedule III Section f Subsection 1 Item 33 Methenolone
    ⇒
    PubChem: 9054; ChemSpider: 2301378; Erowid: Steroids; Wikipedia: Metenolone
    3D rendering of Methyltestosterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Methyltestosterone
    CA: CDSA Schedule IV Section 23 Subsection 25 Methyltestosterone
    US: CSA Schedule III Section f Subsection 1 Item 40 Methyltestosterone
    ⇒
    PubChem: 6010; ChemSpider: 5788; Erowid: Steroids; Wikipedia: Methyltestosterone
    3D rendering of Metribolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Metribolone
    CA: CDSA Schedule IV Section 23 Subsection 26 Metribolone
    US: CSA Schedule III Section f Subsection 1 Item 39 Methyltrienolone
    ⇒
    PubChem: 261000; ChemSpider: 229099; Erowid: Steroids; Wikipedia: Metribolone
    3D rendering of Mibolerone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Mibolerone
    CA: CDSA Schedule IV Section 23 Subsection 27 Mibolerone
    US: CSA Schedule III Section f Subsection 1 Item 41 Mibolerone
    ⇒
    PubChem: 19454; ChemSpider: 220460; Erowid: Steroids; Wikipedia: Mibolerone
    3D rendering of Nandrolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Nandrolone
    CA: CDSA Schedule IV Section 23 Subsection 28 Nandrolone
    US: CSA Schedule III Section f Subsection 1 Item 43 Nandrolone
    ⇒
    PubChem: 9904; ChemSpider: 9520; Erowid: Steroids; Wikipedia: Nandrolone
    3D rendering of 19-Norandrostenedione
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    19-Norandrostenedione
    US: CSA Schedule III Section f Subsection 1 Item 50 19-Nor-5-androstenedione
    ⇒
    PubChem: 18633059; ChemSpider: 18612511; Erowid: Steroids; Wikipedia: 19-Norandrostenedione
    3D rendering of 19-Nor-4-androstene-3,17-dione
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    19-Nor-4-androstene-3,17-dione
    US: CSA Schedule III Section f Subsection 1 Item 49 19-Nor-4-androstenedione
    ⇒
    PubChem: 10221133; ChemSpider: 83803; Erowid: Steroids; Wikipedia: 19-Norandrostenedione
    3D rendering of 19-Nor-5-androstene-3,17-diol
    Effective 1 Jul 2003, S.I. 2003/1243 added:
    19-Nor-5-androstene-3,17-diol
    US: CSA Schedule III Section f Subsection 1 Item 46 19-Nor-5-androstenediol
    ⇒
    PubChem: 23623203; ChemSpider: 19967184; Erowid: Steroids; Wikipedia: Bolandiol
    3D rendering of 19-Norandrosterone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    19-Norandrosterone
    ⇒
    PubChem: 128251 54364459 44361976 14009229 11778226 10016318 9548753; ChemSpider: 7827676; Wikipedia: 19-Norandrosterone
    3D rendering of Norboletone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Norboletone
    CA: CDSA Schedule IV Section 23 Subsection 29 Norboletone
    US: CSA Schedule III Section f Subsection 1 Item 51 Norbolethone
    ⇒
    PubChem: 66255; ChemSpider: 59638; Erowid: Steroids; Wikipedia: Norbolethone
    3D rendering of Norclostebol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Norclostebol
    CA: CDSA Schedule IV Section 23 Subsection 30 Norclostebol
    US: CSA Schedule III Section f Subsection 1 Item 52 Norclostebol
    ⇒
    PubChem: 166576; ChemSpider: 145769; Erowid: Steroids; Wikipedia: Norclostebol
    3D rendering of Norethandrolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Norethandrolone
    CA: CDSA Schedule IV Section 23 Subsection 31 Norethandrolone
    US: CSA Schedule III Section f Subsection 1 Item 53 Norethandrolone
    ⇒
    PubChem: 5858; ChemSpider: 5649; Erowid: Steroids; Wikipedia: Norethandrolone
    3D rendering of 19-Noretiocholanolone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    19-Noretiocholanolone
    ⇒
    PubChem: 54364460 54364458 22795659 14009228 10446174 10891128; ChemSpider: 19347817
    3D rendering of Oripavine
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Oripavine
    UN: Narcotics Part 1 Section 1 Oripavine
    US: CSA Schedule II Section b Subsection 1 Item xii Oripavine
    ⇒
    PubChem: 5462306; ChemSpider: 4575366; Drugs Forum: Oripavine; Wikipedia: Oripavine
    3D rendering of Ovandrotone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Ovandrotone
    ⇒
    PubChem: 57225475
    3D rendering of Oxabolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Oxabolone
    CA: CDSA Schedule IV Section 23 Subsection 32 Oxabolone
    ⇒
    PubChem: 107580; ChemSpider: 16736429
    3D rendering of Oxandrolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Oxandrolone
    CA: CDSA Schedule IV Section 23 Subsection 33 Oxandrolone
    US: CSA Schedule III Section f Subsection 1 Item 55 Oxandrolone
    ⇒
    PubChem: 5878; ChemSpider: 5667; Bluelight: Oxandrolone; Drugs Forum: Oxandrolone; Erowid: Steroids; Wikipedia: Oxandrolone
    3D rendering of Oxymesterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Oxymesterone
    CA: CDSA Schedule IV Section 23 Subsection 34 Oxymesterone
    US: CSA Schedule III Section f Subsection 1 Item 56 Oxymesterone
    ⇒
    PubChem: 72061; ChemSpider: 65047; Erowid: Steroids; Wikipedia: Oxymesterone
    3D rendering of Oxymetholone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Oxymetholone
    CA: CDSA Schedule IV Section 23 Subsection 35 Oxymetholone
    US: CSA Schedule III Section f Subsection 1 Item 57 Oxymetholone
    ⇒
    PubChem: 3032303; ChemSpider: 4444502; Bluelight: Oxymetholone; Erowid: Steroids; Wikipedia: Oxymetholone
    3D rendering of Pipradrol
    Effective 13 Jun 2012, S.I. 2012/1390 added:
    On 28 Feb 2012, S.I. 2012/1390* proposed to add:
    Pipradrol
    CA: CDSA Schedule IV Section 7 Pipradrol
    UN: Psychotropics Schedule IV Pipradrol
    US: CSA Schedule IV Section f Subsection 10 Pipradrol
    UK: Previously at MDA Part III Class C Section 1(a)
    ⇒
    PubChem: 10083; ChemSpider: 9681; Wikipedia: Pipradrol
    3D rendering of Prasterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Prasterone
    CA: CDSA Schedule IV Section 23 Subsection 36 Prasterone
    ⇒
    PubChem: 5881; ChemSpider: 5670; Wikipedia: Dehydroepiandrosterone
    3D rendering of Propetandrol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Propetandrol
    ⇒
    PubChem: 19268; ChemSpider: 16737110; Wikipedia: Propetandrol
    3D rendering of Prostanozol
    Prostanozol
    3D rendering of Prostanozol, O-tetrahydropyran-2-yl
    Prostanozol, O-tetrahydropyran-2-yl
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Prostanozol
    [There is much confusion surrounding the name Prostanozol. The culprit seems to be the World Anti-Doping Agency (WADA), which every year updates their list of Prohibited Substances.

    For 2009 (and later) it reads:
    Prostanozol (17β-Hydroxy-5α-androstano[3,2-c]pyrazole), depicted at left, above.

    For 2008 (and earlier) it reads:
    Prostanozol ([3,2-c]pyrazole-5α-etioallocholane-17β-tetrahydropyranol), depicted at left, below.

    Given these names describe distinctly different substances WADA’s explanation—“The nomenclature of Prostanozol has been changed to better follow the International Union of Pure and Applied Chemistry (IUPAC) rules”—has a certain… CYA quality. Not very helpful WADA. Definitely not very sporting.]
    US: CSA Schedule III Section f Subsection 1 Item 58 Prostanozol and Item 89 [3,2-c]Pyrazole-5α-androstan-17β-ol
    ⇒
    ChemSpider: 10071620; Erowid: Steroids; Wikipedia: Prostanozol
    US: [not controlled] CSA Schedule III Section f Subsection 1 Prostanozol, O-tetrahydropyran-2-yl
    ⇒
    PubChem: 56842253; Erowid: Steroids; Wikipedia: Prostanozol
    3D rendering of Quinbolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Quinbolone
    CA: CDSA Schedule IV Section 23 Subsection 37 Quinbolone
    ⇒
    PubChem: 10360683; ChemSpider: 8536132; Wikipedia: Quinbolone
    3D rendering of Roxibolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Roxibolone
    ⇒
    PubChem: 68795; ChemSpider: 62035; Wikipedia: Roxibolone
    3D rendering of Silandrone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Silandrone
    ⇒
    PubChem: 68627; ChemSpider: 61886; Wikipedia: Silandrone
    3D rendering of Stanolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Stanolone
    CA: CDSA Schedule IV Section 23 Subsection 2 Androstanolone
    US: CSA Schedule III Section f Subsection 1 Item 19 4-Dihydrotestosterone
    ⇒
    PubChem: 10635; ChemSpider: 10189; Erowid: Steroids; Wikipedia: Dihydrotestosterone
    3D rendering of Stanozolol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Stanozolol
    CA: CDSA Schedule IV Section 23 Subsection 38 Stanozolol
    US: CSA Schedule III Section f Subsection 1 Item 59 Stanozolol
    ⇒
    PubChem: 25249; ChemSpider: 23582; Bluelight: Stanozolol; Erowid: Steroids; Wikipedia: Stanozolol
    3D rendering of Stenbolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Stenbolone
    CA: CDSA Schedule IV Section 23 Subsection 39 Stenbolone
    US: CSA Schedule III Section f Subsection 1 Item 60 Stenbolone
    ⇒
    PubChem: 234454; ChemSpider: 204491; Erowid: Steroids; Wikipedia: Stenbolone
    3D rendering of Testosterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Testosterone
    CA: CDSA Schedule IV Section 23 Subsection 40 Testosterone
    US: CSA Schedule III Section f Subsection 1 Item 62 Testosterone
    ⇒
    PubChem: 6013; ChemSpider: 5791; Erowid: Steroids; Wikipedia: Testosterone
    3D rendering of Tetrahydrogestrinone
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Tetrahydrogestrinone
    US: CSA Schedule III Section f Subsection 1 Item 63 Tetrahydrogestrinone
    ⇒
    PubChem: 25320811 6857686; ChemSpider: 5257020; Bluelight: Tetrahydrogestrinone; Erowid: Steroids; Wikipedia: Tetrahydrogestrinone
    3D rendering of Thiomesterone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Thiomesterone
    CA: CDSA Schedule IV Section 23 Subsection 42 Tiomesterone
    ⇒
    PubChem: 16626; ChemSpider: 15763; Wikipedia: Tiomesterone
    3D rendering of Trenbolone
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Trenbolone
    CA: CDSA Schedule IV Section 23 Subsection 43 Trenbolone
    US: CSA Schedule III Section f Subsection 1 Item 64 Trenbolone
    ⇒
    PubChem: 25015; ChemSpider: 23383; Erowid: Steroids; Wikipedia: Trenbolone
    3D rendering of Trilostane
    [Trilostane (above) is explicitly not captured by this clause]
    Hydroxyandrostan-3-one skeleton
    17-Hydroxyandrostan-3-one
    Hydroxyestran-3-one
    17-Hydroxyestran-3-one
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    1(c)
    Any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-Hydroxyandrostan-3-one or from 17-Hydroxyestran-3-one by modification in any of the following ways, that is to say:
    1. by further substitution at position 17 by a methyl or ethyl group;
    2. by substitution to any extent at one or more of the positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
    3. by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
    4. by fusion of ring A with a heterocyclic system.
    ⇒
    PubChem: 656583 51371308 51064132; ChemSpider: 570949; Wikipedia: Trilostane
    ⇒
    PubChem: 57253355 147320 54132599 44403751 44314545 44308180 44307156 44264584 40529478 40528884 25880652 275
    ⇒
    PubChem: 94202 44379952 18647774 12583590 10446172 10016319; ChemSpider: 22888947
    3D rendering of 1-Benzylpiperazine
    1-Benzylpiperazine
    3D rendering of 1-Phenylpiperazine
    1-Phenylpiperazine
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    1(ca)
    1-Benzylpiperazine or any compound structurally derived from 1-Benzylpiperazine or 1-Phenylpiperazine by modification in any of the following ways—
    1. by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;
    2. by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups;
    CA: CDSA Schedule III Section 33 Benzylpiperazine
    EU: Substances Substances 1-Benzylpiperazine
    US: CSA Schedule I Section f Subsection 2 N-Benzylpiperazine
    ⇒
    PubChem: 75994; ChemSpider: 68493; Erowid: BZP; Wikipedia: Benzylpiperazine
    ⇒
    PubChem: 7096; ChemSpider: 6829
    1(d)
    Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above.
    Effective 26 Jan 2009, S.I. 2008/3130 replacement for:
    Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above or of Cannabinol or a Cannabinol derivative.
    Effective 29 Jan 2004, S.I. 2003/3201 replacement for:
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;
    [A glycoprotein heterodimer composed of a 92-amino acid α-subunit and a 145-amino acid β-subunit.]
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    1(e)
    Chorionic gonadotrophin
    ⇒
    PubChem: 4786
    3D rendering of Clenbuterol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Clenbuterol
    ⇒
    PubChem: 2783; ChemSpider: 2681; Wikipedia: Clenbuterol
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Non-human chorionic gonadotrophin
    ⇒
    PubChem: 4786
    [Human growth hormone—a 191-amino acid polypeptide]
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Somatotropin
    ⇒
    PubChem: 4786; Wikipedia: Growth hormone
    [N-L-Methionyl human growth hormone]
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Somatrem
    ⇒
    PubChem: 4786; Wikipedia: Somatrem
    [Human growth hormone—a 191-amino acid polypeptide]
    Effective 1 Sep 1996, S.I. 1996/1300 added:
    Somatropin
    ⇒
    PubChem: 4786; Wikipedia: Growth hormone
    3D rendering of Zeranol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Zeranol
    CA: CDSA Schedule IV Section 24 Zeranol
    ⇒
    PubChem: 22283; ChemSpider: 20916; Wikipedia: Zeranol
    3D rendering of Zilpaterol
    Effective 23 Dec 2009, S.I. 2009/3209 added:
    Zilpaterol
    ⇒
    PubChem: 3086576; Wikipedia: Zilpaterol
    3D rendering of Phenylpropanolamine
    [Phenylpropanolamine (above) is explicitly not captured by this clause]
    2
    Any stereoisomeric form of a substances for the time being specified in paragraph 1 of this Part of this Schedule, not being Phenylpropanolamine.
    Effective 1 Apr 1987, S.I. 1986/2230 replacement for:
    Any stereoisomeric form of a substances for the time being specified in paragraph 1 of this Part of this Schedule.
    ⇒
    PubChem: 4786; ChemSpider: 4622; Wikipedia: Phenylpropanolamine
    3
    Any salt of a substance for the time being specified in paragraph 1or 2 of this Part of this Schedule.
    4
    Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.
    Drug Precursors
    Source: Council and the European Parliament. Regulation (EC) No 273/2004 on drug precursors. 11 February 2004
    Annex I · Category 1
    The stereoisomeric forms of the substances listed in this category not being cathine ((+)-norpseudoephedrine), whenever the existence of such forms is possible.
    The salts of the substances listed in this category, whenever the existence of such salts is possible and not being the salts of cathine.
    3D rendering of 1-Phenyl-2-propanone
    1-Phenyl-2-propanone (Phenylacetone)
    CA: CDSA Schedule VI Part 1 Subsection 11 1-Phenyl-2-propanone
    EU: Drug precursors Annex I Category 1 1-Phenyl-2-propanone
    UN: Precursors Table I 1-Phenyl-2-propanone
    US: CSA Schedule II Section g Subsection 1 Item i Phenylacetone
    ⇒
    PubChem: 7678; ChemSpider: 21106366; Erowid: P2P synthesis; Wikipedia: Phenylacetone
    3D rendering of N-Acetylanthranilic acid
    N-Acetylanthranilic acid (2-Acetamidobenzoic acid)
    CA: CDSA Schedule VI Part 1 Subsection 2 N-Acetylanthranilic acid
    EU: Drug precursors Annex I Category 1 N-Acetylanthranilic acid
    UN: Precursors Table I N-Acetylanthranilic acid
    US: CSA Listed Chemicals Section a Subsection 6 N-Acetylanthranilic acid
    ⇒
    PubChem: 6971; ChemSpider: 6705; Wikipedia: N-Acetylanthranilic Acid
    3D rendering of Isosafrole
    Isosafrole (cis + trans)
    CA: CDSA Schedule VI Part 1 Subsection 7 Isosafrole
    EU: Drug precursors Annex I Category 1 Isosafrole
    UN: Precursors Table I Isosafrole
    US: CSA Listed Chemicals Section a Subsection 16 Isosafrole
    ⇒
    PubChem: 637796; ChemSpider: 21106329; Wikipedia: Isosafrole
    3D rendering of 3,4-Methylenedioxyphenyl-2-propanone
    3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-Benzodioxol-5-yl)propan-2-one)
    CA: CDSA Schedule VI Part 1 Subsection 9 3,4-Methylenedioxyphenyl-2-propanone
    EU: Drug precursors Annex I Category 1 3,4-Methylenedioxyphenylpropan-2-one
    UN: Precursors Table I 3,4-Methylenedioxyphenyl-2-propanone
    US: CSA Listed Chemicals Section a Subsection 12 3,4-Methylenedioxyphenyl-2-propanone
    ⇒
    PubChem: 78407; ChemSpider: 70776; Erowid: MDP2P; Wikipedia: 3,4-Methylenedioxyphenylpropan-2-one
    3D rendering of Piperonal
    Piperonal
    CA: CDSA Schedule VI Part 1 Subsection 14 Piperonal
    EU: Drug precursors Annex I Category 1 Piperonal
    UN: Precursors Table I Piperonal
    US: CSA Listed Chemicals Section a Subsection 18 Piperonal
    ⇒
    PubChem: 8438; ChemSpider: 13859497; Erowid: Piperonal Synthesis; Wikipedia: Piperonal
    3D rendering of Safrole
    Safrole
    CA: CDSA Schedule VI Part 1 Subsection 17 Safrole
    EU: Drug precursors Annex I Category 1 Safrole
    UN: Precursors Table I Safrole
    US: CSA Listed Chemicals Section a Subsection 17 Safrole
    ⇒
    PubChem: 5144; ChemSpider: 13848731; Bluelight: Safrole; Erowid: Safrole Synthesis; Wikipedia: Safrole
    3D rendering of Ephedrine
    Ephedrine
    CA: CDSA Schedule VI Part 1 Subsection 4 Ephedrine
    EU: Drug precursors Annex I Category 1 Ephedrine
    UN: Precursors Table I Ephedrine
    US: CSA Listed Chemicals Section a Subsection 3 Ephedrine
    ⇒
    PubChem: 9294; ChemSpider: 8935; Erowid: Ephedrine; Wikipedia: Ephedrine
    3D rendering of Pseudoephedrine
    Pseudoephedrine
    CA: CDSA Schedule VI Part 1 Subsection 16 Pseudoephedrine
    EU: Drug precursors Annex I Category 1 Pseudoephedrine
    UN: Precursors Table I Pseudoephedrine
    US: CSA Listed Chemicals Section a Subsection 11 Pseudoephedrine
    ⇒
    PubChem: 7028; ChemSpider: 6761; Bluelight: Pseudoephedrine; Drugs Forum: Pseudoephedrine; Erowid: Ephedrine; Wikipedia: Pseudoephedrine
    3D rendering of Norephedrine
    Norephedrine
    CA: CDSA Schedule VI Part 1 Subsection 10 Norephedrine
    EU: Drug precursors Annex I Category 1 Norephedrine
    UN: Precursors Table I Norephedrine
    US: CSA Listed Chemicals Section a Subsection 9 Phenylpropanolamine
    ⇒
    PubChem: 10297 26934; ChemSpider: 9875; Bluelight: Phenylpropanolamine; Erowid: Phenylpropanolamine; Wikipedia: Phenylpropanolamine
    3D rendering of Ergometrine
    Ergometrine
    CA: CDSA Schedule VI Part 1 Subsection 5 Ergometrine
    EU: Drug precursors Annex I Category 1 Ergometrine
    UN: Precursors Table I Ergometrine
    US: CSA Listed Chemicals Section a Subsection 4 Ergonovine
    ⇒
    PubChem: 443884; ChemSpider: 391970; Wikipedia: Ergonovine
    3D rendering of Ergotamine
    Ergotamine
    CA: CDSA Schedule VI Part 1 Subsection 6 Ergotamine
    EU: Drug precursors Annex I Category 1 Ergotamine
    UN: Precursors Table I Ergotamine
    US: CSA Listed Chemicals Section a Subsection 5 Ergotamine
    ⇒
    PubChem: 8223; ChemSpider: 7930; Erowid: Ergot; Wikipedia: Ergotamine
    3D rendering of Lysergic acid
    Lysergic acid
    CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
    EU: Drug precursors Annex I Category 1 Lysergic acid
    UN: Precursors Table I Lysergic acid
    US: CSA Schedule III Section c Subsection 8 Lysergic acid
    ⇒
    PubChem: 6717; ChemSpider: 6461; Wikipedia: Lysergic acid
    Annex I · Category 2
    The salts of the substances listed in this category, whenever the existence of such salts is possible.
    3D rendering of Acetic anhydride
    Acetic anhydride
    CA: CDSA Schedule VI Part 1 Subsection 1 Acetic anhydride
    EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
    UN: Precursors Table I Acetic anhydride
    US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
    See also MDA Drug precursors Annex II Acetic anhydride
    ⇒
    PubChem: 7918; ChemSpider: 7630; Wikipedia: Acetic anhydride
    3D rendering of Phenylacetic acid
    Phenylacetic acid
    CA: CDSA Schedule VI Part 1 Subsection 12 Phenylacetic acid
    EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
    UN: Precursors Table II Phenylacetic acid
    US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
    See also MDA Drug precursors Annex II Phenylacetic acid
    ⇒
    PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
    3D rendering of Anthranilic acid
    Anthranilic acid
    CA: CDSA Schedule VI Part 1 Subsection 3 Anthranilic acid
    EU: Drug precursors Annex I Category 2 Anthranilic acid and Annex II Anthranilic acid
    UN: Precursors Table II Anthranilic acid
    US: CSA Listed Chemicals Section a Subsection 1 Anthranilic acid
    See also MDA Drug precursors Annex II Anthranilic acid
    ⇒
    PubChem: 227; ChemSpider: 222; Wikipedia: Anthranilic acid
    3D rendering of Piperidine
    Piperidine
    CA: CDSA Schedule VI Part 1 Subsection 13 Piperidine
    EU: Drug precursors Annex I Category 2 Piperidine and Annex II Piperidine
    UN: Precursors Table II Piperidine
    US: CSA Listed Chemicals Section a Subsection 10 Piperidine
    See also MDA Drug precursors Annex II Piperidine
    ⇒
    PubChem: 8082; ChemSpider: 7791; Drugs Forum: Piperidines; Erowid: Piperidine; Wikipedia: Piperidine
    3D rendering of Potassium permanganate
    Potassium permanganate
    CA: CDSA Schedule VI Part 1 Subsection 15 Potassium permanganate
    EU: Drug precursors Annex I Category 2 Potassium permanganate and Annex II Potassium permanganate
    UN: Precursors Table I Potassium permanganate
    US: CSA Listed Chemicals Section b Subsection 5 Potassium permanganate
    See also MDA Drug precursors Annex II Potassium permanganate
    ⇒
    PubChem: 516875; ChemSpider: 22810; Bluelight: KMnO4 substitute; Wikipedia: Potassium permanganate
    Annex I · Category 3
    The salts of the substances listed in this category, whenever the existence of such salts is possible and not being the salts of hydrochloric acid and sulphuric acid.
    3D rendering of Hydrochloric acid
    Hydrochloric acid (Hydrogen chloride)
    CA: CDSA Schedule VI Part 2 Subsection 3 Hydrochloric acid
    EU: Drug precursors Annex I Category 3 Hydrochloric acid
    UN: Precursors Table II Hydrochloric acid
    US: CSA Listed Chemicals Section b Subsection 8 Hydrochloric acid
    ⇒
    PubChem: 313; ChemSpider: 307; Wikipedia: Hydrochloric acid
    3D rendering of Sulphuric acid
    Sulphuric acid
    CA: CDSA Schedule VI Part 2 Subsection 5 Sulphuric acid
    EU: Drug precursors Annex I Category 3 Sulphuric acid
    UN: Precursors Table II Sulphuric acid
    US: CSA Listed Chemicals Section b Subsection 9 Sulfuric acid
    ⇒
    PubChem: 1118; ChemSpider: 1086; Bluelight: Sulfuric acid; Wikipedia: Sulfuric acid
    3D rendering of Toluene
    Toluene
    CA: CDSA Schedule VI Part 2 Subsection 6 Toluene
    EU: Drug precursors Annex I Category 3 Toluene
    UN: Precursors Table II Toluene
    US: CSA Listed Chemicals Section b Subsection 7 Toluene
    ⇒
    PubChem: 1140; ChemSpider: 1108; Bluelight: Toluene; Drugs Forum: Toluene; Wikipedia: Toluene
    3D rendering of Ethyl ether
    Ethyl ether (Diethyl ether)
    CA: CDSA Schedule VI Part 2 Subsection 2 Ethyl ether
    EU: Drug precursors Annex I Category 3 Ethyl ether
    UN: Precursors Table II Ethyl ether
    US: CSA Listed Chemicals Section b Subsection 4 Ethyl ether
    ⇒
    PubChem: 3283; ChemSpider: 3168; Erowid: Ether; Wikipedia: Diethyl ether
    3D rendering of Acetone
    Acetone
    CA: CDSA Schedule VI Part 2 Subsection 1 Acetone
    EU: Drug precursors Annex I Category 3 Acetone
    UN: Precursors Table II Acetone
    US: CSA Listed Chemicals Section b Subsection 2 Acetone
    ⇒
    PubChem: 180; ChemSpider: 175; Wikipedia: Acetone
    3D rendering of Methyl ethyl ketone
    Methyl ethyl ketone (Butanone)
    CA: CDSA Schedule VI Part 2 Subsection 4 Methyl ethyl ketone
    EU: Drug precursors Annex I Category 3 Methylethylketone
    UN: Precursors Table II Methyl ethyl ketone
    US: CSA Listed Chemicals Section b Subsection 6 2-Butanone
    ⇒
    PubChem: 6569; ChemSpider: 6321; Wikipedia: Butanone
    Annex II
    3D rendering of Acetic anhydride
    Acetic anhydride
    100 L
    CA: CDSA Schedule VI Part 1 Subsection 1 Acetic anhydride
    EU: Drug precursors Annex I Category 2 Acetic anhydride and Annex II Acetic anhydride
    UN: Precursors Table I Acetic anhydride
    US: CSA Listed Chemicals Section b Subsection 1 Acetic anhydride
    See also MDA Drug precursors Annex I Category 2 Acetic anhydride
    ⇒
    PubChem: 7918; ChemSpider: 7630; Wikipedia: Acetic anhydride
    3D rendering of Potassium permanganate
    Potassium permanganate
    100 L
    CA: CDSA Schedule VI Part 1 Subsection 15 Potassium permanganate
    EU: Drug precursors Annex I Category 2 Potassium permanganate and Annex II Potassium permanganate
    UN: Precursors Table I Potassium permanganate
    US: CSA Listed Chemicals Section b Subsection 5 Potassium permanganate
    See also MDA Drug precursors Annex I Category 2 Potassium permanganate
    ⇒
    PubChem: 516875; ChemSpider: 22810; Bluelight: KMnO4 substitute; Wikipedia: Potassium permanganate
    3D rendering of Anthranilic acid
    Anthranilic acid
    1 kg
    CA: CDSA Schedule VI Part 1 Subsection 3 Anthranilic acid
    EU: Drug precursors Annex I Category 2 Anthranilic acid and Annex II Anthranilic acid
    UN: Precursors Table II Anthranilic acid
    US: CSA Listed Chemicals Section a Subsection 1 Anthranilic acid
    See also MDA Drug precursors Annex I Category 2 Anthranilic acid
    ⇒
    PubChem: 227; ChemSpider: 222; Wikipedia: Anthranilic acid
    3D rendering of Phenylacetic acid
    Phenylacetic acid
    1 kg
    CA: CDSA Schedule VI Part 1 Subsection 12 Phenylacetic acid
    EU: Drug precursors Annex I Category 2 Phenylacetic acid and Annex II Phenylacetic acid
    UN: Precursors Table II Phenylacetic acid
    US: CSA Listed Chemicals Section a Subsection 8 Phenylacetic acid
    See also MDA Drug precursors Annex I Category 2 Phenylacetic acid
    ⇒
    PubChem: 999; ChemSpider: 10181341; Erowid: Phenylacetic acid synthesis; Wikipedia: Phenylacetic acid
    3D rendering of Piperidine
    Piperidine
    0.5 kg
    CA: CDSA Schedule VI Part 1 Subsection 13 Piperidine
    EU: Drug precursors Annex I Category 2 Piperidine and Annex II Piperidine
    UN: Precursors Table II Piperidine
    US: CSA Listed Chemicals Section a Subsection 10 Piperidine
    See also MDA Drug precursors Annex I Category 2 Piperidine
    ⇒
    PubChem: 8082; ChemSpider: 7791; Drugs Forum: Piperidines; Erowid: Piperidine; Wikipedia: Piperidine
    Drugs Subject to Temporary Control
    3D rendering of 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
    Effective 5 Apr 2012, S.I. 2012/980 added, for one year’s duration:
    2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone (Methoxetamine)
    • (a) 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
    • (b) any stereoisomeric form of 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone;
    • (c) any ester or ether of a substance specified in paragraph (a) or (b);
    • (d) any salt of a substance specified in any of paragraphs (a) to (c); and
    • (e) any preparation or other product containing a substance specified in any of paragraphs (a) to (d).
    EU: Substances Substances 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
    UK: Currently at MDA Part II Class B Section 1(d) Methoxetamine
    ⇒
    PubChem: 52911279; ChemSpider: 24721792; Bluelight: Methoxetamine; Drugs Forum: Methoxetamine; Erowid: Methoxetamine; Wikipedia: Methoxetamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1.
    The following substances, namely—
    3D rendering of 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
    US: CSA Schedule I Section h Subsection 4 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    US: [proposed] CSA Schedule I Section d Subsection 48 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    ⇒
    PubChem: 10251906; ChemSpider: 8427392; Bluelight: 25I-NBOMe; Drugs Forum: 25I-NBOMe; Erowid: 25I-NBOMe; Wikipedia: 25I-NBOMe
    3D rendering of 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    US: CSA Schedule I Section h Subsection 6 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    US: [proposed] CSA Schedule I Section d Subsection 50 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    ⇒
    PubChem: 9977044; ChemSpider: 8152636; Bluelight: 25B-NBOMe; Drugs Forum: 25B-NBOMe; Wikipedia: 25B-NBOMe
    3D rendering of 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    UK: Currently at MDA Part I Class A Section 1(f) 2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    ⇒
    ChemSpider: 29341727; Drugs Forum: 25D-NBOMe; Wikipedia: 25D-NBOMe
    3D rendering of 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    US: CSA Schedule I Section h Subsection 5 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    US: [proposed] CSA Schedule I Section d Subsection 49 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
    UK: Currently at MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
    ⇒
    PubChem: 46856354; ChemSpider: 24583389; Bluelight: 25C-NBOMe; Drugs Forum: 25C-NBOMe; Erowid: 25C-NBOMe; Wikipedia: 25C-NBOMe
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    2.
    The following substances, namely—
    3D rendering of 1-(Benzofuran-5-yl)-propan-2-amine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(Benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives
    UK: Currently at MDA Part II Class B Section 1(e) 1-(Benzofuran-5-yl)-propan-2-amine
    ⇒
    PubChem: 9837232; ChemSpider: 8012953; Drugs Forum: 5-APB; Wikipedia: 5-APB
    3D rendering of 1-(Benzofuran-6-yl)-propan-2-amine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(Benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives
    UK: Currently at MDA Part II Class B Section 1(e) 1-(Benzofuran-6-yl)-propan-2-amine
    ⇒
    PubChem: 9794343; ChemSpider: 7970110; Bluelight: 6-APB; Drugs Forum: 6-APB; Erowid: 6-APB; Wikipedia: 6-APB
    3D rendering of 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine and its N-methyl derivatives
    UK: Currently at MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine
    ⇒
    PubChem: 192601; ChemSpider: 167143; Drugs Forum: 5-APDB; Wikipedia: 5-APDB
    3D rendering of 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine and its N-methyl derivatives
    UK: Currently at MDA Part II Class B Section 1(e) 1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine
    ⇒
    PubChem: 192599; ChemSpider: 167141; Wikipedia: 6-APDB
    3D rendering of 1-(1H-Indol-5-yl)-1-methylethylamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(1H-Indol-5-yl)-1-methylethylamine
    EU: Substances Substances 5-(2-Aminopropyl)indole
    UK: Currently at MDA Part II Class B Section 1(e) 1-(1H-Indol-5-yl)-1-methylethylamine
    ⇒
    PubChem: 55253543; ChemSpider: 25991467; Erowid: 5-IT (5-(2-Aminopropyl)indole); Wikipedia: 5-(2-Aminopropyl)indole
    3D rendering of 1-(1H-Indol-6-yl)-1-methylethylamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    1-(1H-Indol-6-yl)-1-methylethylamine
    UK: Currently at MDA Part II Class B Section 1(e) 1-(1H-Indol-6-yl)-1-methylethylamine
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    3.
    Any stereoisomeric form of a substance specified in paragraph 1 or 2.
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    4.
    Any salt of a substance specified in any of paragraphs 1 to 3.
    Effective 10 Jun 2013, S.I. 2013/1294 added, for one year’s duration:
    5.
    Any preparation or other product containing a substance specified in any of paragraphs 1 to 4.
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    1.
    The following substances, namely—
    3D rendering of 3,4-Dichloromethylphenidate
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    3,4-Dichloromethylphenidate (3,4-DCMP)
    See also MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
    ⇒
    PubChem: 44418862; ChemSpider: 23278471; Wikipedia: 3,4-Dichloromethylphenidate
    3D rendering of Ethylphenidate
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    Ethylphenidate
    See also MDA Temporary Class Drug Orders 2015 Ethylphenidate
    ⇒
    PubChem: 3080846; ChemSpider: 2338571; Drugs Forum: Ethylphenidate; Erowid: Ethylphenidate; Wikipedia: Ethylphenidate
    3D rendering of Isopropylphenidate
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    Isopropylphenidate (IPP; IPPD)
    See also MDA Temporary Class Drug Orders 2015 Isopropylphenidate
    ⇒
    PubChem: 68314762; Wikipedia: Isopropylphenidate
    3D rendering of Methylnaphthidate
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    Methylnaphthidate (HDMP-28)
    See also MDA Temporary Class Drug Orders 2015 Methylnaphthidate
    ⇒
    PubChem: 49823708; ChemSpider: 24818258; Wikipedia: HDMP-28
    3D rendering of Propylphenidate
    Effective 10 Apr 2015, S.I. 2015/1027 added, for one year’s duration:
    Propylphenidate
    See also MDA Temporary Class Drug Orders 2015 Propylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    1.
    The following substances, namely—
    With thanks to Niflheim for pointing out all of S.I. 2015/1396 had been missed—note the impersonal passive construction suggesting an act of God ;)
    3D rendering of 3,4-Dichloromethylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    3,4-Dichloromethylphenidate (3,4-DCMP)
    See also MDA Temporary Class Drug Orders 2015 3,4-Dichloromethylphenidate
    ⇒
    PubChem: 44418862; ChemSpider: 23278471; Wikipedia: 3,4-Dichloromethylphenidate
    3D rendering of 4-Methylmethylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    4-Methylmethylphenidate
    ⇒
    PubChem: 44296147; ChemSpider: 8281556; Wikipedia: 4-Methylmethylphenidate
    3D rendering of Ethylnaphthidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    Ethylnaphthidate
    ⇒
    PubChem: 91844468; Wikipedia: HDEP-28
    3D rendering of Ethylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    Ethylphenidate
    See also MDA Temporary Class Drug Orders 2015 Ethylphenidate
    ⇒
    PubChem: 3080846; ChemSpider: 2338571; Drugs Forum: Ethylphenidate; Erowid: Ethylphenidate; Wikipedia: Ethylphenidate
    3D rendering of Isopropylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    Isopropylphenidate (IPP; IPPD)
    See also MDA Temporary Class Drug Orders 2015 Isopropylphenidate
    ⇒
    PubChem: 68314762; Wikipedia: Isopropylphenidate
    3D rendering of Methylnaphthidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    Methylnaphthidate (HDMP-28)
    See also MDA Temporary Class Drug Orders 2015 Methylnaphthidate
    ⇒
    PubChem: 49823708; ChemSpider: 24818258; Wikipedia: HDMP-28
    3D rendering of Propylphenidate
    Effective 27 Jun 2015, S.I. 2015/1396 added, for one year’s duration:
    Propylphenidate
    See also MDA Temporary Class Drug Orders 2015 Propylphenidate
    3D rendering of N-Methyl-1-(thiophen-2-yl)propan-2-amine
    Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
    (a)
    N-Methyl-1-(thiophen-2-yl)propan-2-amine (Methiopropamine; MPA);
    ⇒
    PubChem: 436156; ChemSpider: 385727; Erowid: Methiopropamine; Wikipedia: Methiopropamine
    Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
    (b)
    any stereoisomeric form of N-Methyl-1-(thiophen-2-yl)propan-2-amine;
    Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
    (c)
    any salt of a substance specified in paragraph (a) or (b); and
    Effective 27 Nov 2015, S.I. 2015/1929 added, for one year’s duration:
    (d)
    any preparation or other product containing a substance specified in any of paragraphs (a) to (c).
    11 March 2016 · Creative Commons BY-NC-SA ·